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COMPARITIVE STUDY OF INTRATHECAL 
ROPIVACAINE –FENTANYL AND BUPIVACAINE- FENTANYL 
FOR LOWER LIMB ORTHOPAEDIC SURGERIES 
 
Aim 
 
                          Intrathecal bupivacaine results in a longer duration of complete  
anaesthetic block than ropivacaine. Fentanyl used as an adjuvant may improve  
the quality of spinal block of ropivacaine, while maintaining its advantage of  
early motor recovery. 
                         The aim of the study was to compare the efficacy and safety of    
intrathecal  ropivacaine‑fentanyl (RF) with bupivacaine‑fentanyl (BF) for  lower  
limb orthopaedic surgeries. 
 
Methods 
 
                       In this Single Centered, Prospective, Randomized, Parallel group,  
Double – Blind study, sixty patients were randomly allocated to receive either  
intrathecal 15  mg  of 0.5%  ropivacaine with 25 mcg fentanyl (Group RF) or  
15 mg of 0.5% bupivacaine with 25 mcg fentanyl (Group BF). The onset,  
duration, spread of  sensory and motor block, haemodynamic parameters and  
side effects  were recorded. 
                 
                        Data analysis was done by using SPSS software and Sigma  
Stat 3.5 version (2012). 
 
 
Results 
 
                           Time to reach highest sensory level, complete motor block and  
two segment  sensory  regression time were comparable. The motor recovery  
to Bromage scale 1 was faster in Group RF. The haemodynamic stability was  
better in Group RF. Time duration of  analgesia was prolonged in Group BF .  
 
Conclusion 
 
                    Intrathecal RF provided satisfactory anaesthesia with 
Haemodynamic stability for lower limb orthopaedic surgeries. It provided a  
similar sensory but a shorter duration of motor block compared to BF, which is  
a desirable feature for early ambulation, voiding and physiotherapy. 
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INTRODUCTION 
 
Spinal Anaesthesia is the widely used method for lower limb orthopaedic 
surgeries, providing a faster onset and effective motor and sensory blockade. It is 
simple, easy to perform and has got a definite endpoint.   
Intrathecal bupivacaine is widely used in spinal anaesthesia over a long 
period of time. 
In this setting, a newer drug Ropivacaine has emerged, which is being 
widely used for epidural blocks and nerve plexus blocks. Ropivacaine has an 
improved safety profile over bupivacaine with respect to central nervous system 
and cardio toxic potential. Though ropivacaine is being used frequently, in 
epidural and nerve blocks, the literature regarding its use in intrathecal route is 
sparse. 
 
 
 
 
 
 
 
 
HISTORY OF SPINAL ANAESTHESIA 
 
J.Leonard corning 1855 – 1923, A New York Neurologist, in 1885, while 
experimenting with cocaine on the spinal nerves, he accidentally pierced the dura 
of a dog.  Later he deliberately repeated the intradural injection, called it spinal 
anesthesia and suggested it can be used in surgical procedures. 
Heinrich Irchacus Quinke (1842 -1922) of Germany in 1891 and Essex 
wynter (1860 – 1945) in England, had standardized lumbar puncture in the same 
year. 
In 1892 –the term ‘conduction anaesthesia’ was introduced by Heinrich 
Braun August Bier (1861 – 1949) in August 1898 in Kiel- Germany had 
performed the first planned spinal analgesia for surgery in man performed by 
injecting 3ml of 0.5% cocaine solution intrathecally into a 34 years old labourer.  
In 1902,   Heinrich Braun used Adrenaline to reduce toxicity and to 
increase the duration of spinal analgesia. 
In 1957, Bupivacaine was synthesized by Ekenstam 
In 1963, Bupivacaine was used clinically by LJ Telivuo 
In 1979, Albright reported cardiac arrest following regional anesthesia 
using local anesthetics bupivacaine and etidocaine. He also reported presumed 
accidental intra vascular injection of either bupivacaine or etidocaine leading to 
sudden ventricular arrhythmias and also as severe convulsions. 
This sequence of events provided the need to develop a newer local 
anesthetic drug with improved safety profile. 
In 1996, Ropivacaine was introduced in clinical practice, and has 
consistently demonstrated an improved safety profiles over bupivacaine with a 
reduced CNS and cardio toxic profile. 
Ropivacaine was approved for intrathecal administration by the European 
Union in February 2004. 
ANATOMY& PHYSIOLOGY 
 
The vertebral canal covering the human spinal cord extends from the 
foramen magnum to the sacral hiatus. The vertebral column forming the 
vertebral canal consists of 
                    Cervical          7 
                    Thoracic        12  
                    Lumbar           5 vertebrae.  
                    The sacrum     5 and  
                    The coccyx     4 fused segments. 
The adult spine has four curvatures-  
Cervical and Lumbar - convex forwards (lordosis), which are formed by 
postural alignment. 
Thoracic and Sacral -concave forwards (kyphosis).formed by the actual 
configuration of the vertebrae. 
The vertebrae are held together by a number of overlapping ligaments 
namely 
1. Anterior longitudinal ligament - On the anterior surface of the  
Vertebral body 
2. Posterior longitudinal ligament - On the posterior surface of  
      Vertebral body. 
3. The Ligamentum flavum- Running from lamina to lamina composed of 
yellow elastic fibers and it is thicker from above downwards. 
4. Supraspinous ligament 
5. Inter spinous ligament and 
6. Intervertebral discs. 
 
 
 
 
 
 
  
 
 
 
Certain common palpable landmarks that usually correspond to a 
particular level include 
1. The seventh cervical vertebra - the most prominent spinous process 
2. The seventh thoracic vertebra -inferior angle of scapula  
3. Tuffier’s line, the line connecting the two iliac crests almost 
Crosses the vertebral column at the level of L4-L5 intervertebral space. 
The intervertebral canal consists of: 
1. Roots of spinal nerves 
2. Spinal membrane with the spinal cord and cerebrospinal Fluid. 
3. Vessels, fat and areolar tissue. 
The spinal cord is the continuation of medulla oblongata and it ends 
below in conus medullaris from which filum terminale, descends vertically as 
cauda eqina. From the upper border of atlas, the Spinal cord extends upto the 
lower border of first lumbar vertebra in adults. The spinal cord extends till the 
upper border of the second lumbar vertebra, and still lower in infants. 
The coverings of spinal cord from inside to outside are 
 Piamater. 
 Arachnoidmater 
 Duramater. 
The Duramater is attached to the margins of the foramen magnum above 
and ends at the level of lower border of second sacral vertebra below. From the 
Spinal Cord, the posterior and anterior nerve roots pierce the investing layer of 
duramater, and carries the prolongation (dural cuff). The dural cuff then blends 
with the perineurium of mixed spinal nerve. 
The Arachnoid mater is a thin transparent sheath which is closely applied 
to the duramater. The subdural space is a potential space which allows the dura 
and arachnoid to move over each other. It contains a small amount of serous 
fluid. 
The spinal cord is invested closely by the Piamater. From each lateral 
surface of the piamater, the denticulate ligament projects into the subarachnoid 
space.  The piamater inferiorly ends as a prolongation, which is termed as the 
filum terminale, gets attached to the periosteum of coccyx after penetrating the 
distal end of the dural sac. 
The subarachnoid space is filled with the cerebrospinal fluid and it 
contains the denticulate ligament and the spinal nerve roots. Lumbar puncture is 
routinely done below the second lumbar vertebra to L5-S1 interspace in order to 
avoid damage to the spinal cord, which ends at the lower border of first lumbar 
vertebra. 
Blood supply of spinal cord 
The spinal cord receives its blood supply mainly from three Longitudinal 
arterial channels namely 
 One anterior spinal artery, arising by the union of a small branch from 
each vertebral artery and it supplies the lateral and the anterior columns.   
 Two posterior spinal arteries, branches of posterior inferior cerebellar 
arteries on each side, with no anastomosis between them, supply the 
posterior columns of the cord. 
The spinal arteries also receive blood through radicular arteries that 
reaches the cord along the roots of spinal nerves. These radicular arteries arise 
from the vertebral, ascending cervical, deep cervical, the intercostals, lumbar and 
sacral arteries. The arteria radicularis magna, also called as Artery of 
Adamkiewicz, is the largest of the radicular arteries and it may be responsible for 
supplying blood to the lower two-thirds of the spinal cord. It is variable in 
position. There is no anastomosis between the anterior spinal artery and the 
posterior spinal artery. So if thrombosis occurs in any of these arteries, spinal 
cord infarction will occur. 
The Venous drainage of the spinal cord is mainly through six longitudinal 
venous channels. They are; 
1. Anteromedian and 
2. Postero median venous channels 
3. Two pairs of Anterolateral and Posterolateral channels. 
These channels join together forming a venous plexus, from where the 
venous blood drains through the radicular vein into the vertebral veins in the 
neck, the azygos veins in the thorax, the lumbar veins in the abdomen and the 
lateral sacral veins in the pelvis. 
 
 
CEREBROSPINAL FLUID 
The cerebrospinal fluid is an Ultra filtrate of plasma secreted by the 
choroid plexus of the third, fourth and lateral ventricles at a rate of 0.3 to 
0.5ml/min.  
The average volume of CSF ranges from 120 to 150 ml, of which 25 ml is 
in the cerebral subarachnoid space, 35 ml in the ventricles and about 75 ml is in 
the spinal subarachnoid space. It is a colourless liquid with slight opalescence 
due to the presence of globulin. 
Circulation of cerebrospinal fluid 
The CSF is produced as an Ultra filtrate by the choroid plexuses of the 
lateral ventricles, passes through the interventricular foramina (of Monro) into 
the third ventricle, and then through the cerebral aqueduct (of Sylvius) into the 
fourth ventricle.  CSF flows through foramen of Magendie and foramen of 
Luschka to reach the spinal subarachnoid space.   The amount of CSF in spinal 
canal is 75 ml with a pressure of 70-180 mm of H2O in lateral position and about 
375-500mm of H2O in vertical position. 
The cerebrospinal fluid is absorbed mainly into the venous system, 
through the arachnoid villi and the arachnoid granulations. These are most 
numerous in superior sagittal sinus and its lateral lacunae. Approximately 300-
380 ml of cerebrospinal fluid enters venous circulation each day. 
An important factor determining the spread of drug in CSF is the specific 
gravity of the drug , in relation to that of CSF, which is 1.003 – 1.009 
(average1.004).  Hyperbaric solution is one which is denser than CSF at C.   
The Specific gravity of 10% Dextrose, used commonly in the so called 
heavy or hyperbaric solutions is 1.034. 
Physical Characteristics of Cerebrospinal Fluid 
pH: 7.4 
Specific gravity at body temperature: 1.007 
Specific gravity at 4 degree Celsius: 1.0003 
Density: 1.0003gm/ml 
Baricity: 1.000 
Cells: 3 – 5 / cu.mm 
Proteins: 20mg / dl 
Glucose: 45 – 80 mg/dl 
THE SPINAL CORD 
The Spinal Cord is a part of the nervous system, which occupies the upper 
2/3 of the vertebral canal, and is usually 45cm long.  It extends from upper 
border of the atlas to the upper border of the second lumbar vertebra, and lower 
still in infants.  It is continuous as medulla oblongata upwards and ends below in 
conus medullaris.  The nerve roots which pass out in transverse direction in early 
life becomes more oblique in direction in adults.  They are bathed in CSF and 
will be readily affected by the local analgesic solution injected in the lumbar 
area.  
SEGMENTS OF SPINAL CORD: 
The spinal cord is divided into many segments by the pairs of spinal 
nerves, which arise from it.  These pairs are 31 in number. 
a) Cervical               8 
b) Thoracic               12 
c) Lumbar                 5 
d) Sacral                    5   and 
e) Coccygeal             1 
The nerve roots within the duramater have no epineural sheaths, so they 
are easily affected by the local analgesics.  The cord is not transversely blocked 
by spinal analgesia. 
Spinal nerves; 
Anterior root is efferent and motor.  The Posterior root is larger than 
anterior and is largely sensory.  Posterior root has a ganglion and it conveys 
fibers of all sensation with automatic fibers. 
Pain pathway in the spinal cord: 
Pain and temperature fibers enter the posterior horn, where they end 
around cells in the grey matter. These fibers then cross to the contra lateral side 
within two to three segments, and then ascend to the thalamus via the lateral 
spino thalamic tract.  Tactile impulses ascend through the ventral spinothalamic 
tract to the thalamus. The deep pressure and muscle sensory impulses ascend 
through the posterior columns and the spinocerebellar tracts. The Vibration sense 
impulses ascend in the posterior columns. 
The Anterior and posterior nerve roots within its sheath unite in the 
intervertebral foramen to form the main trunk, which soon divide into anterior 
and posterior divisions. 
Local analgesic drugs injected into the sub arachnoid space can traverse 
along the nerve trunk for as much as 2cm beyond the inter vertebral foramen. 
The Analgesic drugs affect autonomic, sensory and motor fibers in that order and 
fibers which gets blocked easily will hold the drug longest, and thus sensory 
block lasts longer than motor, and usually ascends two segments higher up the 
cord than motor block. 
Segmental levels: 
Clavicle      C3 – C4 
Second inter costal space  T2 
Nipple line    T4 – T5 
Sub costal arch   T6 – T8 
Umbilicus    T10 
Inguinal region    L1 
Perineum    S1 – S4 
Segmental levels of spinal reflexes: 
Epigastric   T7 T8 
Abdominal  T9 - T12 
Cremasteric  L1 L2 
Plantar  S1 S2  
MECHANISM OF ACTION OF LOCAL ANESTHETIC DRUGS 
The Local anesthetic solution which is injected into the subarachnoid 
space gets mixed with the cerebrospinal fluid, and comes into contact with the 
spinal cord and the peripheral nerve roots. The nerve roots leaving the spinal 
canal gets exposed readily to the local anesthetic solution, since they are not 
covered with epithelium. Local anesthetic drugs prevent the nerve impulse 
transmission (conduction blockade) by inhibiting the passage of sodium ions, 
through the ion-selective sodium channels in nerve membranes. The failure of 
the sodium ion channel permeability to increase, in turn leads to slowing down of 
the rate of depolarization, so that a threshold potential is not reached, and so an 
action potential is not propagated. These local anesthetic drugs do not alter the 
resting membrane potential or the threshold potential. 
Zone of Differential Blockade 
In subarachnoid block, sympathetic fibers are blocked about two to six 
segments higher than the sensory fibers. When more concentrated solutions are 
used or when adrenaline is added, sympathetic block will be greater. Motor block 
will be two segments below the level of sensory block. 
Nerve fibers are blocked in the following order; 
1. Autonomic preganglionic B fibers, 
2. Temperature fibers- Cold fibers first, then followed by warm fibers 
3. Pinprick fibers 
4. Fibers conveying pain, greater than pin prick 
5. Touch fibers 
6. Deep pressure fibers 
7. Somatic motor fibers 
8. Fibers conveying vibratory sense and proprioceptive impulses. 
During recovery, the sensations return in the reverse order, but it has been 
suggested that the sympathetic activity returns before sensation. 
 
 
 
   
 
 
 
 
 Subarachnoid block 
 
SPREAD OF LOCAL ANAESTHETICS IN SUBARACHNOID 
SPACE 
The local anesthetic drug is diluted by CSF and therefore its original 
concentration is less than the actual mass of drug injected. Spread is also 
determined by the baricity of the injected solution. Baricity is a ratio of 
comparing the densities of a local anesthetic solution at a specific temperature, 
with the density of CSF at the same temperature. A hypobaric solution has a 
baricity of less than 1.0000 or specific gravity less than 1.0069 (the mean value 
of specific gravity). A hyperbaric solution has a baricity of greater than 1.0000 or 
specific gravity more than 1.0069. Hypobaric and Hyperbaric solutions are 
prepared from isobaric solutions by the addition of various amounts of sterile 
distilled water and dextrose respectively. Isobaric solutions do not move under 
the influence of gravity in the CSF. Hyperbaric solutions, being heavier than 
CSF, settle to the most dependent aspect of the subarachnoid space, which is 
determined by the position of the patient. In supine patient, hyperbaric solutions 
gravitate to the thoracic kyphosis. Hypobaric solution floats up against the 
gravity to the nerves innervating the corresponding area supplying the surgical 
site. 
FATE OF LOCAL ANAESTHETICS IN SUBARACHNOID SPACE 
 
After injection of local anesthetic solution into subarachnoid space, its 
concentration falls rapidly. The initial steep fall is due to the mixing of local 
anesthetic with CSF and subsequent absorption into nerve roots and spinal cord. 
The removal of local anesthetic solution following subarachnoid injection is 
primarily by the mechanism of vascular absorption. Depending on the type of the 
drug used, it is metabolized in plasma by pseudo cholinesterase or in the liver. 
The addition of a vasoconstrictor to the local anesthetic solution will increase the 
duration of anaesthesia by decreasing the absorption of the drug. 
PHYSIOLOGICAL EFFECTS OF SUBARACHNOID BLOCK 
 
Cardiovascular effects 
The vasomotor tone is determined by the sympathetic fibers which are 
arising fromT5 to L1 and innervating the arterial and venous smooth muscles. 
Hence sympathetic block will cause a decrease in the blood pressure, which may 
be accompanied by bradycardia. With high sympathetic blockade, sympathetic 
cardiac accelerator fibers arising at T1-T4 are blocked, leading to a decreased 
cardiac contractility. Bezod -Jarisch reflex has been known as a cause of 
hypotension, bradycardia, and cardiovascular collapse after central neuraxial 
blockade, and in particular, subarachnoid block. 
Respiratory effects 
Even with high thoracic levels, the tidal volume remains unchanged. A 
small decrease in the vital capacity is due to paralysis of abdominal muscles 
which are necessary for forced exhalation, and not due to phrenic nerve 
involvement or impaired diaphragmatic function. Effective coughing and 
clearing of secretions may get affected with higher levels of block. Respiratory 
arrest associated with spinal anaesthesia is rare and is due to hypo perfusion of 
respiratory centers in the brain stem. 
Gastrointestinal function 
Nausea and vomiting is seen in up to 20% of patients. It is due to gastro 
intestinal hyperperistalsis caused by unopposed parasympathetic activity. Vagal 
tone dominance results in a small and contracted gut with active peristalsis and 
can provide excellent operative conditions. The Hepatic blood flow will decrease 
with reductions in mean arterial pressure. 
Renal function 
Renal function has a wide physiological reserve.  Any decrease in the 
renal blood flow is of little physiological importance. Neuraxial blocks 
frequently causes urinary retention, which delays the discharge of out patients 
and necessitates urinary bladder catheterization of inpatients. 
 
INDICATIONS FOR SUBARACHNOID BLOCK 
 
  Spinal anaesthesia can be administered usually for surgeries such as 
• Lower abdominal surgeries 
• Lower limb surgeries 
• Urological procedures 
• Obstetric procedures 
• Gynecological surgeries 
• Perineal and rectal surgeries 
 
 
CONTRAINDICATIONS FOR SUBARACHNOID BLOCK 
 
  The absolute contraindication for subarachnoid block are 
• Patient refusal 
• Local sepsis 
    The relative contraindications include 
• Raised intracranial pressure 
• Coagulopathy 
• Neurological disease 
• Fixed cardiac output states 
• Any documented allergy to local anesthetics 
• Major spine deformities or previous surgery on the spine 
• Hemodynamic instability. 
 
 
 
 
 
FACTORS INFLUENCING HEIGHT OF ANALGESIA IN  
SUB ARACHNOID BLOCK 
 
• Dose of the drug injected 
• Volume of fluid injected 
• Specific gravity of the anesthetic drug solution 
• Position of the patient during injection 
• Posture of the patient after injection 
• Choice of interspace 
• Patient factors- Age, Height and Pregnancy 
 
FACTORS NOT INFLUENCING HEIGHT OF ANALGESIA IN 
SUBARACHNOID BLOCK 
 
• Patient factors- Weight, Sex. 
• Barbotage. 
• Rate of speed of injection. 
• Composition and circulation of cerebrospinal fluid. 
• Direction of bevel of the standard needle (although not of the Whitacare 
   needle). 
 
 
 
COMPLICATIONS OF SUBARACHNOID BLOCK 
 
The Immediate complications include 
• Hypotension 
• Bradycardia 
• Toxicity due to intravascular injection 
• Allergic reaction to local Anesthetic 
• Hypoventilation (brain stem hypoxia) 
The late complications include 
• Post-dural puncture headache 
• Retention of urine 
• Backache 
• Meningitis 
• Transient neurological symptoms 
• Cauda equine syndrome 
• Anterior spinal artery syndrome 
• Horner’s syndrome 
 
 
 
 
LOCAL ANAESTHETIC DRUGS 
Local anesthetic agents are divided into two groups namely the Amides and 
esters 
Esters 
                   1.Benzocaine 
                   2.Chloroprocaine 
                   3.Cocaine 
                   4.Cyclomethycaine 
                   5.Dimethocaine 
                   6.Piperocaine 
                   7. Propoxycaine 
                   8.Procaine 
                   9.Proparacaine 
                   10.Tetracaine/Amethocaine 
 
Amides 
                   1. Articaine 
                   2. Bupivacaine 
                   3. Dibucaine 
                   4. Etidocaine 
                   5. Levobupivacaine 
                   6. Lignocaine 
                   7.Mepivacaine 
                   8. Prilocaine 
                   9. Ropivacaine 
                   10. Trimecaine 
Adjuvants used in spinal anesthesia 
Adjuvants are intended to prolong the local anesthetic analgesia and reduce 
their toxic doses. Some of the adjuvants used intrathecally are  
Opioids- 
Morphine, Diamorphine, Fentanyl, Sufentanyl 
Clonidine 
Ketamine 
Neostigmine 
Adrenaline 
Phenylepherine 
Sodium bicarbonate 
 
 
 
 
 
 
 
BUPIVACAINE 
 
Bupivacaine, an amino amide local anesthetic. It was first synthesized in 
Sweden by A.F Ekenstam and his colleagues in 1957.First report of its use was 
in 1963 by L.J Teluvio. It is one of the long acting local anesthetic agents 
available,which is extensively used for intrathecal, extradural and peripheral 
nerve blocks. It is a white crystalline powder soluble in water. 
 
CHEMICAL STRUCTURE OF BUPIVACAINE 
1-butyl-n-(2, 6 –dimethylphenyl) piperidine-2-carboxamide 
Physiochemical properties 
• Molecular formula; C18 H28 N2OHCl 
• Molecular weight; 288.43 g/mol 
• Solubility in water 25mg/ml 
• pH of saturated solution 5.2 
• pKa 8.1 
• Specific gravity 1.021 at 37 ◦ C 
• Melting point 247 – 258 ◦ C 
Mechanism of action: 
Mechanism of action of bupivacaine is similar to that of any other local 
anaesthetic .The primary action of local anaesthetics is on the cell membrane 
axon, on which it produces electrical stabilization. Bupivacaine prevents the 
nerve impulse transmission (conduction blockade) by the inhibition of the 
sodium ion passage through the ion-selective sodium channels in the nerve 
membranes. The sodium channel is a specific receptor for the local anaesthetic 
molecules. Failure of the sodium ion channel permeability leads to slowing down 
of the rate of depolarization, so that the threshold potential is not reached, and 
thus an action potential is not propagated. Local anaesthetics do not alter the 
resting transmembrane potential or the threshold potential. The mechanism by 
which local anaesthetics block sodium conductance is as follows: 
 
1. Local anaesthetics in the cationic form act on the receptors within the sodium 
channels on cell membrane and block it. The local anaesthetics can reach the 
sodium channel either via the lipophilic pathway directly across the lipid 
membrane, or via the axoplasmic opening. This mechanism accounts for 90% of 
the nerve blocking effects of amide local anaesthetics. 
 
2. The second mechanism of action is by membrane expansion. This is a 
non specific drug receptor interaction. 
 
Other site of action targets: 
• Voltage dependent potassium ion channels 
• Calcium ion currents (L-type most sensitive) 
• G protein coupled receptors 
 
Dosage depends on: 
• Area to be anaesthetized 
• Number of nerve segments to be blocked 
• Individual tolerance to the drug 
• Technique of administration of local anaesthesia. 
• Vascularity of area 
Bupivacaine is available in the following concentrations: 
• 0.25%. 0.5%and 1% 
• 0.25% and 0.5% solution in isotonic saline 
• 0.5% solution in 8% dextrose 
Dosage is 2mg/kg limited to 150 mg in four hours. The intrathecal minimum 
local analgesic dose of Bupivacaine is 2.37 mg. 
 
Type of block Concentration 
% 
Dosage in 
ml 
Dosage in 
mg 
Local infiltration  
0.25 – 0.5 
 
5 – 20 
 
Up to 175 mg 
Intercostal nerve block 0.25 – 0.5 3 – 5 /nerve 15 – 20/nerve 
Brachial plexus Block 0.25 – 0.5 15 – 30 75 – 225 
Caudal block 0.25 – 0.5 15 - 30 75 – 150 
Epidural block 0.25 – 0.5 15 – 30 50 - 200 
Sub arachnoid 
block 
 
0.5 – 0.75 02-04 10-20 
These doses may be repeated in 3 -4 hrs, but the maximum dose in 24 hrs 
is 400 mg. Addition of vasoconstrictor produces a very slight increase in the 
duration of action. However the peak blood level of bupivacaine is significantly 
reduced, thereby minimizing the systemic toxicity. 
ANESTHETIC POTENCY: 
Hydrophobicity appears to be a primary determinant of the intrinsic 
anesthetic potency, and Bupivacaine is highly hydrophobic, hence it is very 
potent. 
ONSET OF ACTION: 
The onset of conduction blockade   depends on the dose of the local anesthetic 
used. The onset of action of Bupivacaine is between 4– 6 mins and maximum 
anaesthesia  is obtained in  15 – 20 minutes. 
DURATION OF BLOCK: 
The duration of anesthesia varies according to the type of block, the 
average duration of peridural block is about 3.5 – 5 hours, it is about 5 – 6 hours 
for nerve blocks. 
PHARMACOKINETICS: 
The concentration of Bupivacaine in blood is determined by the amount 
injected, the rate of absorption from the site of injection, the rate of tissue 
distribution, vascularity and the rate of biotransformation and excretion of 
Bupivacaine. Bupivacaine can be detected in the blood within 5 mins of 
infiltration or following epidural or intercostals nerve blocks. Plasma levels are 
related to the total dose administered.  
Peak levels of 0.14 to1.18 μg/ml were found within 5 mins to 2 hrs, and 
they will gradually decline to 0.1 to 0.34 μg/ml by 4 hrs. 
PLASMA BINDING: 
In plasma, drug binds avidly with protein to the extent of 70 -90%. 
ABSORPTION: 
The site of injection of drug used, dose and the addition of a 
vasoconstrictor determine the systemic absorption of Bupivacaine. The 
maximum level of Bupivacaine in the blood is related to the total dose of the 
drug administered from any particular site. Absorption is faster in areas of high 
vascular supply. 
TOXICITY 
The toxic plasma concentration is set at 4 – 5 μg/ml. Maximum plasma 
concentration rarely approach toxic levels. Ventricular arrhythmias, and 
ventricular fibrillation may occur more often after rapid administration of large 
doses of bupivacaine intra venously. 
The pregnant patient is more sensitive to cardiotoxic effects of 
bupivacaine. 0.75% bupivacaine is no longer recommended for its use in 
obstetric anaesthesia. 
There is no established role of antiarrhythmic drugs or traditional drugs in 
the setting of bupivacaine induced cardiac arrest.  The first treatment for 
accidental intra vascular injection of overdose of anaesthetic are 
                    -   Securing the airway 
                    -   Oxygenation, ventilation 
DISTRIBUTION: 
The two-compartment model can describe this. The rapid distribution 
phase is mainly due to the uptake by rapidly equilibrating tissues. i.e.,the tissues 
having high vascularity. The slow distribution phase is mainly a function of 
distribution to slowly equilibrating tissues, biotransformation of the drug and 
excretion of the compound. More highly perfused organs show higher 
concentrations of the drug. Bupivacaine is rapidly excreted by the lung tissue. 
Though skeletal muscles does not show any particular affinity for bupivacaine, 
they are the largest reservoir of the drug. 
 
 
 
 
DISTRIBUTION CHARACTERISTICS: 
T1/2: 2-7 minutes (uptake by rapid equilibrium tissue) 
T1/2: 28 minutes (distribution by slowly perfused tissues) 
T1/2: 3-5 hours (metabolism and elimination) 
VDSS: 72 liters (volume of distribution at steady state) 
 
Pharmacodynamics: 
Central Nervous System: 
Bupivacaine readily crosses the blood brain barrier, causing CNS 
depression following higher doses. The initial symptoms of CNS toxicity involve 
feeling of dizziness, and light-headedness followed by auditory and visual 
disturbances. Drowsiness and disorientation may occur. Objective signs, are 
usually excitatory in nature, which includes muscular twitches, tremors and 
shivering, characterized by involvement of muscles of the face (perioral 
numbness) and part of the extremities. At still higher doses, cardiovascular or 
respiratory arrest may occur. Acidosis will increase the risk of CNS toxicity from 
Bupivacaine, since an elevation of the PaCO2 enhances the cerebral blood flow, 
which leads to more of anesthetic being delivered rapidly to the brain. 
Autonomic nervous system: 
Bupivacaine does not inhibit the Noradrenaline uptake and hence has no 
sympathetic potentiating effect. Myelinated preganglionic B fibers have a faster 
conduction time, and they are more sensitive to the action of Bupivacaine. When 
used for conduction blockade, all local anesthetics, in particular-bupivacaine 
produces higher incidence of sensory than motor fibers. 
Cardiovascular System 
The primary cardiac electrophysiological effect of a local anesthetic is a 
decrease in the maximum rate of depolarization in Purkinje fibers and ventricular 
muscle. This action by Bupivacaine is far greater when compared to Lignocaine. 
Also, the rate of recovery of block is slower with Bupivacaine. Therefore there is 
complete restoration of Vmax between action potential particularly at higher 
rates. Therefore Bupivacaine is highly arrythmogenic. Bupivacaine reduces the 
cardiac contractility by blocking the calcium transport. Low concentration of 
Bupivacaine produces vasoconstriction whereas high doses cause vasodilatation. 
Respiratory System: 
Respiratory depression may be caused if an excessive plasma level is 
reached, and will result in the   depression of medullary receptor center. The 
depression of respiration may be also caused by paralysis of the respiratory   
muscles of diaphragm, as may occur in high spinal or total spinal   anesthesia. 
Biotransformation and Excretion: 
Bupivacaine undergoes the process of enzymatic degradation primarily in 
the liver. The excretion occurs primarily via the kidney. Urinary excretion is 
affected by renal perfusion and factors that affect the urinary pH. Less than 5% 
of bupivacaine is excreted through the kidney unchanged through urine. The 
major portion of injected drug appears in urine in the form of 2, 6 
pipecolyoxylidine (ppx), which is a n-dealkylated metabolite. The renal 
clearance of the drug is inversely related to its capacity of protein binding and 
pH of urine. 
Adverse Effects: 
Adverse effects are encountered in clinical practice mostly due 
To overdose, inadvertent injection intravascularly, or slow metabolic 
degradation. 
CNS: 
It is characterized by excitation, or depression. The first symptom may be 
nervousness, dizziness, blurring of vision or tremors, which is followed by 
drowsiness, convulsions, unconsciousness and finally respiratory arrest. 
CVS: 
Myocardial depression, hypotension, arrhythmia, ventricular type 
conduction defect, SA node depression and cardiac arrest. 
ALLERGIC REACTIONS: 
Utricaria, bronchospasm, hypotension. 
 
OTHERS: 
Nausea, vomiting, chills, constriction of pupil and tinnitus. 
ROPIVACAINE 
    
 
 
 
 
 
History  
Long acting local anaesthetic bupivacaine was released in 1965. Although 
bupivacaine has been the local anaesthetic of choice for decades with long 
duration of action, when given accidentally as intravascular, it produces 
irreversible cardio vascular collapse.  Cardio toxicity with bupivacaine often 
proves difficult (or) impossible to treat.  Prolonged motor block is another 
drawback of Bupivacaine.  Because of these problems newer agents were looked 
into and Ropivacaine was released in 1996 and only recently launched in India. 
Pharmacology 
It is an amide group of local anaesthetic drug.  It comes in the group of 
mepivacaine and bupivacaine.  Instead of methyl group in mepivacaine, 
ropivacaine has a propyl group and bupivacaine has a butyl group. Mepivacaine 
and bupivacaine are currently used clinically as a racemic mixture of 
enantiomers containing equal properties of ‘R’ and ‘S’ forms. Ropivacaine is 
prepared from the alkylation of S-enantiomer of dibenzoil-L-tartaric acid. 
 
The Pure-S-enantiomer is available as a preservative free clear solution in 
ampoules or vials in concentration of 0.2%, 0.5% and 0.75%.  The solution has 
pH of 4.6 with a pKa 8.1.  It binds extensively with plasma proteins (mainly one 
& acid glycoprotein) metabolized mainly in the liver and excreted by the 
kidneys.  It readily crosses the placenta.  The Pharmacodynamic parameters are 
similar to other amide agents.  Like other local anaesthetic drugs ropivacaine 
works by reversible inhibition of Na+ ion influx in nerve fibers and thereby 
temporarily stopping electrical conduction. 
It is 10 times less lipid soluble when compared to bupivacaine and hence 
they are less likely to penetrate the larger myelinated motor fibers. It has a more 
selective action on A and C fibers as compared to A fibers.  It has a less 
depression of cardiac conductivity and QRS interval.  It is available only as 
isobaric solution. 
Isobaric verses Hyperbaric Solution: 
Density of a solution is the weight in gms of 1ml of that solution at 370C. 
Specific gravity is the ratio of the density of the solution with the density 
of the   water.  
Baricity is defined as the ratio obtained by comparing the density of one 
solution to another. 
To make a drug hypobaric to CSF, it must be less dense than CSF 
i.e.1, 0000 
By adding water and warming the drug to 370C from 40C, it becomes 
hypobaric. 
Dose: 
 Upto 3mg per kg. 
 Based on patient. 
 Route of administration and type of surgery. 
Contraindication: 
 Allergy to amide LA 
 Bier’s block – i.v regional anesthesia. 
Uses: 
 Epidural / caudal block 
 Intra thecal block 
 Nerve block 
 Local infiltration 
 Local instillation 
To establish a surgical anaesthesia through an epidural 10 – 20mls of 
0.5% to 0.75% Ropivacaine is used depending on patient size and height of the 
block required.  For postop and labour pain relief using an epidural 10mls/hr of 
0.2%.  Ropivacaine with fentanyl 2-4mg/ml can be used. 
When used in epidural infusions 0.2% Ropivacaine is used for nerve 
blocks is fast with the motor block wearing off much earlier than compared to 
Bupivacaine. 
It is available as only isobaric solution.  Spinal Ropivacaine (0.75%) 2.5 – 
4 mls with additives like Fentanyl and clonidine offers a reliable cardio stable 
anaesthesia of the lower abdomen and limbs.  Speed of onset is slower when 
compared to Bupivacaine. 
For the same volume intrathecal, the height of the block with isobaric 
Ropivacaine 0.75% is significantly lower as compared to hyperbaric Bupivacaine 
(0.5%) Addition of clonidine, Dexmedetomidine prolongs analgesia upto 16hrs 
(Beware Bradycardia). 
The Safety of Ropivacaine has been studied extensively.  In a classic 
canine study (aroban in 2001), open chested dogs were randomized to escalating 
infusions of Bupivacaine, Ropivacaine and Levobupivacaine to permit collapse 
of the cardiovascular system. 
Unsuccessful resuscitation from Ropivacaine, levobupivacaine and 
Bupivacaine was 10%, 30% and 50%.  Larger doses and blood concentrations of 
Ropivacaine was well tolerated when compared to Levobupivacaine and 
Bupivacaine.  Several studies and case reports have also established the safety of 
the Ropivacaine. 
Cardiotoxicity of local anesthetics may be compared by the use of 
CC/CNS dose ratio. It is defined as the ratio of the dose causing cardiac collapse 
(CC) to the dose causing convulsions. The lower the number, the more 
cardiotoxic is the drug (ex. The CC/CNS for bupivacaine is approximately 3 
versus 5 for ropivacaine). 
  
 
REVIEW OF LITERATURE 
 
Gaurav Kuthiala and Geeta Chaudhary [1] reviewed the pharmacological 
use of ropivacaine. They described that ropivacaine causes a reversible sodium 
ion influx inhibition, thereby it blocks the conduction of impulse in nerve fibers. 
This action of ropivacaine is potentiated by the inhibition of the potassium 
channels in a dose-dependent manner. The lipophilicity of ropivacaine is less 
when compared to bupivacaine, and so is less likely to penetrate the large 
myelinated motor fibers; and so, it has selective action on A δ and C nerves 
which were transmitting pain, comparing to Aβ fibers, which are involved in the 
motor function. 
Luck et al [2] used equal doses of hyperbaric bupivacaine, ropivacaine and 
levobupivacaine (15 mg) intrathecally for elective surgery, and found that 
ropivacaine provided spinal anaesthesia of shorter duration when compared to 
levobupivacaine and bupivacaine, and they concluded that the recovery profile of 
ropivacaine is useful, where early mobilization is required. eg.orthopaedic 
surgeries for early physiotherapy. 
Koltka et al [3] compared doses of equal potency of the isobaric 
bupivacaine- 13 mg and ropivacaine-19.5 mg and, both with fentanyl- 20 mcg 
for the sub-arachnoid block in lower abdominal surgery. They found that the RF 
had a lower level of sensory block with a shorter duration of motor block, when 
compared to BF. 
In a study by Lee et al [4], equal doses of intrathecal ropivacaine and 
bupivacaine (10 mg) with 15 mcg fentanyl were used for urology surgeries, and 
they reported that ropivacaine provided a similar level of sensory anaesthesia, 
but a shorter duration of motor block, in comparison to bupivacaine. 
Chung CJ, Park JS, Yun SH, Hwang GB, Chin YJ [5] had assessed the 
effects of fentanyl, added with hyperbaric ropivacaine in spinal anesthesia in 
cesarean section. Adding fentanyl 10 micro g with hyperbaric ropivacaine 18 mg 
in spinal anesthesia for caesarean section improves the quality of intraoperative 
anesthesia and significantly increases the quality of analgesia in early 
postoperative period. 
Graf BM [6] and his colleagues hypothesized that the differences in direct 
cardiovascular effects are distinguished, by the stereo selective actions of the 
molecules of the local anesthetic drug to specific receptors, and also by the 
physicochemical differences that have been triggered by the replacement of the 
butyl- by a propyl-residual on pipecoloxylide. They concluded that neither of the 
anesthetics showed inotropic effects due to stereo selective property, but the 
isomers of ropicavaine had lesser cardio depressant effects compared to isomers 
of bupivacaine because of the replacement of butyl group - by a propyl-terminal 
group. 
Sangeeta Varun et al [7], hypothesized that intrathecal use of ropivacaine, 
provides a similar anaesthesia with lesser duration of motor blockade when 
compared to bupivacaine. In their study, they concluded that the intrathecal use 
of ropivacaine- fentanyl, has a faster onset, and a faster sensory regression, 
delayed onset, but a comparable motor block regression, and shorter duration of 
analgesia when compared to intrathecal bupivacaine-fentanyl. They also 
concluded that ropivacaine-fentanyl when administered intrathecally, is 
associated with decreased episodes of hypotension, when compared to 
bupivacaine-fentanyl group combination. 
A Yegin et al [8] had evaluated the effects of adding 25 micrograms of 
fentanyl intrathecally to 18 mg (6 mg/ ml) of hyperbaric ropivacaine, on the 
characteristics of spinal block undergoing TURP surgery, and the duration of 
postoperative pain relief in those patients. They concluded that adding fentanyl 
25 micrograms intrathecally will improve the quality of analgesia significantly, 
and prolong the duration of analgesia, without causing a substantial increase in 
the major side-effects. 
Prashanth.K.Gupta [9],and his colleagues had conducted a study which  
aimed at evaluating the clinical safety and efficacy  of intrathecal fentanyl, used 
as an adjuvant to 0.75% isobaric ropivacaine on the  onset, duration, intensity, 
and recovery time of sensory,  and motor  block of subarachnoid block for infra 
umbilical surgery.  They concluded that using Intrathecal use of fentanyl, as an 
adjuvant to 0.75% isobaric ropivacaine had demonstrated a better clinical profile 
when compared to ropivacaine alone. 
Singh [10] and his colleagues had studied the effect of intrathecal fentanyl 
on the onset, and the duration of hyperbaric bupivacaine-induced spinal block in 
adult male patients undergoing genitourinary or lower extremity surgeries. They 
concluded that adding fentanyl, 25 micrograms prolongs the duration of 
bupivacaine-induced sensory blockade and also reduced the requirement of 
analgesia in the early postoperative period. 
A Chaudhary et al [11] had conducted a study, evaluated the efficacy of 
intrathecal ropivacaine alone or in combination with fentanyl for transurethral 
resection operation, which showed that the addition of intrathecal fentanyl to 
ropivacaine may offer the advantage of hemodynamic stability, shorter duration 
of complete motor blockade, and without any increase in the frequency of major 
side effects. 
Malinovsky JM [12] and his colleagues compared intrathecal use of 
ropivacaine to bupivacaine in patients scheduled for TURP .They concluded that 
using 15 mg of intrathecal ropivacaine provides a similar motor and 
hemodynamic effects, but less potent anesthesia when compared to 10 mg of 
bupivacaine for endoscopic urological surgery. 
McNamee et al [13] studied to compare the efficacy and safety of two 
different concentrations of intrathecal ropivacaine, 7.5 and 10 mg/ ml, for 
patients undergoing total hip arthroplasty. They concluded that Intrathecal 
ropivacaine, in doses of 18.75 and 25 mg, was well tolerated and had provided 
an effective anaesthesia for total hip arthroplasty. 
D. Hughes et al [14] conducted a study, aimed to reduce the incidence of 
motor blockade in combined spinal and epidural technique, in labour analgesia. 
They compared the intrathecal use of bupivacaine 2.5 mg with ropivacaine 2.5 
mg, both with fentanyl 25 micrograms. They came to a conclusion  that 
ropivacaine 2.5 mg, when used intrathecally in combination with fentanyl 25 
micrograms, as part of a CSE technique had provided a safe and rapid onset of  
analgesia for labour, but with a lesser motor blockade when compared to a same 
dose of  bupivacaine   
Anita R Chhabra et al [15] had compared the efficacies of intrathecal 
adjuvants with isobaric ropivacaine for major lower limb surgeries. They 
compared   60 micrograms of clonidine with 25 micrograms of fentanyl, when 
either of them was used as adjuvant along with 15 mg of isobaric ropivacaine 
intrathecally, in major surgeries of the lower limb. They observed that clonidine, 
when used as an adjuvant intrathecally, provided a denser and longer duration of 
motor blockade, prolonged duration of sensory blockade, and a longer duration 
of post-operative analgesia when compared to fentanyl. 
N Boztug et al [16]   compared the effects of two different doses of 
intrathecal ropivacaine 8 mg and 10 mg ,with fentanyl 25 micrograms as 
adjuvant for out-patient arthroscopic knee surgeries. They concluded that 8 mg 
of intrathecal ropivacaine with 25 microgram of fentanyl provided shorter 
duration of sensory and motor block, compare to higher dose of 10 mg. They 
also concluded that small doses of ropivacaine together with fentanyl can be used 
safely for arthroscopic knee surgeries. 
 Wahedi W et al [17] in their randomised, double-blind study, administered   
intrathecally two different doses of ropivacaine 5mg/ml and 7.5mg/ml. A volume 
of 3ml was injected intrathecally to forty patients and they recorded the spinal 
block characteristics. They concluded that ropivacaine results in long-lasting 
spinal anaesthesia at concentrations of 0.5% (5mg/ml) and 0.75% (7.5 mg/ml). 
Buckenmaier CC, Nielsen KC, Pietrobon R, Klein SM, Martin AH, 
Greengrass RA, and Steele SM [18] had compared the efficacy of ropivacaine as 
an alternative to lidocaine, in patients undergoing anorectal procedures as 
outpatient basis. 
They compared intrathecal administration of hyperbaric lidocaine 25 mg 
with fentanyl 20 micrograms with hyperbaric ropivacaine 4 mg with fentanyl 20 
micrograms. They concluded that intrathecal hyperbaric small-dose of 
ropivacaine with fentanyl is an acceptable anesthetic for anorectal surgeries. 
Venkata HG [19] and his colleagues compared the duration of analgesia 
and hemodynamics using a low dose (7.5 mg) bupivacaine- fentanyl mixture 
with a conventional dose (10 mg) of hyperbaric bupivacaine for cesarean section. 
They compared between 10 mg of hyperbaric bupivacaine, and a drug 
combination containing 25 microgram fentanyl and 7.5 mg of hyperbaric 
bupivacaine, posted for elective caesarean section .They concluded that, in 
caesarean section, the combination of low dose bupivacaine 7.5mg and fentanyl 
25 microgram is hemodynamically stable, and has a  prolonged duration of 
analgesia   when comparison to bupivacaine alone. 
Bogra J et al [20] compared different doses of intrathecal bupivacaine alone 
and in combination with fentanyl,for caesarean section. The patient received one 
of the following dose i.e 8mg, 10mg, 12.5mg of bupivacaine alone, or in 
combination with 12.5 microgram of fentanyl. They concluded fentanyl is able to 
reduce the dose of bupivacaine, due to its synergistic effect on bupivacaine, and 
therefore reducing its harmful effects. 
Van Kleef JW et al [21] aimed to determine the safety and clinical efficacy 
of ropivacaine, as a local anesthetic for spinal anesthesia. They studied by using 
either 3 mL of isobaric solution containing 0.5% (15 mg), or 0.75% (22.5 mg) 
ropivacaine. They concluded that subarachnoid injection of isobaric ropivacaine 
solutions results in a variable analgesic spread, and mostly accompanied by a 
good quality of motor block, in particular with the 0.75% solution. 
 
 
 
 
 
 
 
 
 
AIM OF THE STUDY 
The aim of study is to compare the efficacy and safety of intra thecal 
Ropivacaine- Fentanyl and Bupivacaine-Fentanyl for lower limb Orthopaedic 
surgeries, with respect to 
1. Primary  outcome-  spinal block characteristics 
2. Secondary outcome- haemodynamic effects and side effects. 
 
MATERIALS AND METHODS 
Study setting and design 
It is a single centre, prospective, randomized, parallel group, 
 double – blind study. This study was done in Tirunelveli medical college 
hospital at department of Anaesthesiology and critical care. 
After obtaining institutional ethical committee approval, 60 patients 
between the age group of 18-60 were posted for elective lower limb orthopaedic 
surgeries were recruited for the study.  These 60 patients were randomized using 
a computer generated table, into two groups of 30 patients each as follows- 
 
Group RF - 15 mg of 0.5% Ropivacaine (3.0 ml) + 25 mcg Fentanyl (0.5 ml) 
 
Group BF - 15 mg of 0.5% Bupivacaine (3.0 ml) + 25 mcg Fentanyl (0.5 ml) 
 
INCLUSION CRITERIA 
 
• ASA physical status 1 & 2 
• Age 18 – 60 years 
• Both gender 
• Lower limb orthopaedic surgery  
 
 
EXCLUSION CRITERIA 
 
• Known hypersensitivity to any of the test drugs 
• Any contra – indication to spinal anaesthesia 
• Cardiac arrhythmias 
PROCEDURE 
 
Masking 
Pre-filled labelled syringes loaded with the drugs were prepared by an 
anaesthesiologist not participating in the study. The anaesthesiologist who did 
the intervention and observation was unaware of the contents of the syringes and 
the group allocation. 
When the patient arrived the operation room, IV access was established, 
and 500 ml of RL was started. Multipara monitor attached, and baseline 
parameters - EGG, NIBP, SPO2, respiratory rate were recorded. After skin 
infiltration with 2% lidocaine, 25GQuincke’s needle was inserted through L3-4 
interspace in the midline, with the patient in sitting position. Correct placement 
of the needle was identified by free flow of cerebrospinal fluid and 3.5 ml of the 
study drug was injected over 10 seconds, and the patient was then placed supine. 
Standard monitoring was used throughout the surgical procedure. ECG 
and pulse– oximetry were continuously monitored, while NIBP was measured at 
5-min intervals. Heart rate and NIBP were recorded before intrathecal injection, 
3, 5, 15, 30 minutes after the intrathecal drug administration, and thereafter every 
30 minutes till the end of the surgery and one hour after the end of the surgery, at 
the ward. Any hypotension (systolic blood pressure lower than 20% from the 
baseline) was treated with i.v ephedrine 6 mg and bradycardia (heart rate < 
50/min) incidents was treated i.v atropine 0.6 mg increments. 
 
PARAMETERS OBSERVED 
 
PRIMARY 
Spinal block characteristics – 
Time to reach peak sensory level - Pinprick test 
Time to reach peak motor block - Bromage scale grade 3 
Two segment sensory regression time 
Time to motor regression to Bromage scale grade 1 
Duration of analgesia  
Post –operative period - 
Time to first analgesic demand (VAS > 4) 
 
SECONDARY 
                           Heart rate    (< 50 /min - bradycardia) 
                           Blood pressure (> 20 % fall from baseline SBP - hypotension) 
                           Oxygen saturation 
                           Pruritus 
                           Nausea  
                           Vomiting 
                           Shivering 
Sensory score: 
Score Response 
0 normal sensation 
1 loss of pin prick sensation -analgesia 
2 loss of touch sensation - anesthesia 
 
Bromage motor scale: 
Grade Response Degree of  motor block 
0 No motor block  Nil (0%) 
1 Unable to  raise  the straight leg  Partial (33%) 
2 Unable to flex the knee against resistance Almost complete (66%) 
3 Unable to flex the  ankle Complete 
 
TIME OF ONSET OF SENSORY BLOCK 
The time interval between end of anesthetic injection and appearance of 
cutaneous analgesia in the dermatomes assessed by the pin prick test using 20 G 
hypodermic needle in  T-12, T-10, T-8, T-6 or higher levels ( T-4) 
 
 MOTOR BLOCK DURATION 
It is the time taken between administration of anesthetic and the 
attainment of grade 0 in Bromage motor scale. 
 
 
TWO SEGMENT SENSORY REGRESSION TIME 
 
The time taken for the sensory block to regress to two segment down from 
the maximum level of blockade is defined as the two segment regression time 
 
DURATION OF ANALGESIA 
 
It is the time of administration of anesthetic and the disappearance of 
cutaneous level of sensation, at each dermatomal level. 
 
POST-OP ANALGESIA DURATION 
 
The time between the administration of anesthetic and time of analgesic 
requirement (visual analog scale > 4) in PACU. 
 
Visual analog scale 
 
1        2           3         4          5          6          7           8          9     10  
 
 
 
 
 
ANALYSIS AND   RESULTS 
 
Statistical Analysis: 
 
The information which was collected regarding all the selected cases, 
were recorded in a master chart. Data analysis was done with the help of 
computer by using SPSS software and Sigma Stat 3.5 version (2012). Using this 
software, percentage, mean, standard deviation and ‘p’ value were calculated 
through one way ANOVA, and Chi square test and a P value of < 0.05 was taken 
as significant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
AGE DISTRIBUTION 
 
Age in years 
Group 
RF 
Group 
BF 
21 - 30 9 5 
31 - 40 4 4 
41 - 50 4 9 
51 - 60 13 12 
Total 30 30 
Mean 42.97 44.93 
SD 13.91 10.83 
p value 
0.544    
Not significant 
The age distribution between two groups were comparable. 
GENDER DISTRIBUTION 
 
 
 
                     The distribution of gender between the two groups was 
comparable.ie statistically not significant. 
 
 
Gender 
Group 
RF 
Group 
BF 
Male 25 25 
Female 5 5 
Total 30 30 
p value 
0.848    
Not significant 
COMPARISON OF WEIGHT 
 
 
 
Weight 
Group 
RF 
Group 
BF 
Mean 69.5 68.37 
SD 7.22 5.01 
p value 
0.482   
Not significant 
The mean weight distribution between two groups were comparable. i.e 
statistically not significant. 
 
COMPARISON OF HEIGHT 
 
Height 
Group 
RF 
Group 
BF 
Mean 167.83 166.7 
SD 8.11 7.75 
p value 
0.582   
Not significant 
 
The mean distribution of height between two groups were comparable. i.e 
statistically not significant. 
 
 
 
PEAK SENSORY LEVEL (THORACIC) 
 
Peak sensory 
level 
(thoracic) 
Group 
RF 
Group 
BF 
Mean 4.37 4.6 
SD 0.85 0.77 
p value 
0.270  
Not significant 
 
                  The peak sensory levels attained between the two groups were 
comparable. They are statistically not significant. 
 
 
TIME TO REACH PEAK SENSORY LEVEL 
 
Time to reach 
peak sensory 
level in min 
Group 
RF 
Group 
BF 
Mean 6.17 6.17 
SD 0.91 0.79 
p value 
1.0   
Not significant 
 
                   The time to reach peak sensory level between the two groups is 
statistically not significant. 
  
  
 
 The distribution of pulse rates between the two groups were comparable. 
ie, statistically not significant. 
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COMPARISON OF SPO2
Group RF Group BF
 
 The distribution of SPO2 between the two groups were 
comparable. ie,  There is no statistical  significance between the two groups in 
relation to SPO2. 
  The distribution of diastolic blood pressure between the two groups were 
comparable .ie, there is no statistical significance between the two groups in 
relation to diastolic BP. 
 
  The distribution of mean arterial pressure between the two groups were 
comparable .ie, statistically not significant. 
 
 TWO SEGMENT SENSORY REGRESSION TIME 
 
 
Two segment 
sensory 
Regression 
time 
Group 
RF 
Group 
BF 
Mean 65.43 67.03 
SD 3.12 3.71 
p value 
0.076   
Not significant 
 
The two segment sensory regression time between the two groups were 
comparable. i.e statistically not significant. 
COMPARISON OF SYSTOLIC BP 
 
 
After an initial moderate fall produced by the sympathetic blockade in 
both  groups, the  systolic BP got stabilized after 90 min in  RF group, indicated 
by the  recovery of BP to a higher level comparing to BF group , This reflects the 
better  haemodynamic stability in RF group. 
There is a statistical significant difference among the two groups with 
respect to systolic blood pressure. 
This also coincides with the early recovery of motor power in RF group, 
when compared to the BF group. 
 
 
SYSTOLIC BLOOD PRESSURE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There was statistically significant difference in the systolic blood pressure 
between the two groups from 120 to 240 minutes. i.e p < 0.05. ie. There is early 
stabilization of systolic BP in group RF. 
 
Systolic 
BP 
Group 
RF 
Group 
BF SD SD P 
Min 0 124.6 121.5 3.73 2.45 <0.001 
3 122.4 118.5 4.79 4.52 0.002 
5 121.2 116.5 3.52 4.31 <0.001 
15 116.9 115.3 2.55 1.91 0.006 
30 109.3 111.8 2.02 2.76 <0.001 
60 107.6 108.5 2.88 3.98 0.333 
90 108.0 106.7 2.70 3.15 0.021 
120 113.2 107.8 2.24 1.06 <0.001 
150 114.2 109.9 2.49 0.96 <0.001 
180 118.7 111.0 1.51 1.47 <0.001 
210 119.1 111.8 1.76 1.16 <0.001 
240 118.8 111.9 3.24 1.88 <0.001 
270 119.0 114.3 2.44 2.20 <0.001 
300 118.5 116.0 2.79 1.88 <0.001 
Min 330 119.1 116.0 0.83 1.68 <0.001 
DURATION OF MOTOR BLOCK 
Ropivacaine 
Duration of motor block in minutes. 
 
0 5 10 30 60 90 120 150 180 210 240 270 300 330 
 
0 2 3 3 3 3 3 2 2 2 2 1 1 1
0 3 3 3 3 3 3 3 3 3 3 2 1 1
0 3 3 3 3 3 3 3 2 2 2 2 1 1
0 3 3 3 3 3 3 2 2 2 2 2 1 0
0 3 3 3 3 3 3 3 3 3 1 0 0 0
0 3 3 3 3 3 3 3 3 3 3 2 1 0
0 2 3 3 3 3 3 3 2 2 2 2 1 1
0 3 3 3 3 3 3 1 1 1 1 0 0 0
0 3 3 3 3 3 3 3 2 2 1 1 1 0
0 3 3 3 3 3 3 3 2 2 2 1 1 0
0 3 3 3 3 3 3 2 2 1 1 0 1 0
0 2 3 3 3 3 3 3 2 2 2 1 1 0
0 3 3 3 3 3 3 3 2 2 1 1 0 0
0 3 3 3 3 3 3 3 3 3 3 2 1 1
0 3 3 3 3 3 3 2 2 2 1 1 0 0
0 3 3 3 3 3 3 3 2 1 1 0 0 0
0 2 3 3 3 3 3 3 3 2 1 1 0 0
0 3 3 3 3 3 3 3 3 3 1 1 1 1
0 3 3 3 3 3 3 2 2 1 1 0 0 0
0 3 3 3 3 3 3 3 3 2 1 1 1 0
0 3 3 3 3 3 3 3 3 2 1 1 1 0
0 2 3 3 3 3 3 3 3 3 1 1 0 0
0 3 3 3 3 3 3 2 2 1 1 0 0 0
0 3 3 3 3 3 3 3 3 1 1 1 1 0
0 3 3 3 3 3 3 3 3 1 1 1 1 0
0 3 3 3 3 3 3 3 3 1 1 1 0 0
0 3 3 3 3 3 3 3 2 1 1 1 1 1
0 2 3 3 3 3 3 3 3 1 1 1 0 0
0 3 3 3 3 3 3 3 3 1 1 1 0 0
0 3 3 3 3 3 3 3 3 1 1 1 1 1  
 
Bromage scale  
There is an early recovery of motor block in ropivacaine –fentanyl   group 
when compared to bupivacaine-fentanyl group. Most patients had full motor 
recovery by 300 minutes. 
 
 Bupivacaine 
 
Duration of motor block in minutes. 
 
0 5 10 30 60 90 120 150 180 210 240 270 300 330 
 
0 3 3 3 3 3 3 3 3 3 2 2 1 1
0 3 3 3 3 3 3 3 3 2 2 2 1 1
0 3 3 3 3 3 3 3 3 2 2 2 1 1
0 3 3 3 3 3 3 3 3 2 1 1 1 0
0 3 3 3 3 3 3 3 3 3 2 2 2 1
0 3 3 3 3 3 3 3 3 2 2 2 1 1
0 2 3 3 3 3 3 3 3 2 1 1 1 1
0 3 3 3 3 3 3 3 3 2 2 2 2 1
0 3 3 3 3 3 3 3 3 3 2 1 1 1
0 3 3 3 3 3 3 3 3 2 2 2 2 1
0 3 3 3 3 3 3 3 2 1 1 1 1 1
0 2 3 3 3 3 3 3 3 3 2 2 1 1
0 3 3 3 3 3 3 3 2 2 1 1 1 1
0 2 3 3 3 3 3 3 3 2 2 2 2 1
0 3 3 3 3 3 3 3 2 2 1 1 1 1
0 3 3 3 3 3 3 3 3 2 2 2 2 1
0 3 3 3 3 3 3 3 3 3 2 1 1 0
0 3 3 3 3 3 3 3 2 1 1 1 1 1
0 3 3 3 3 3 3 3 3 2 1 1 1 1
0 3 3 3 3 3 3 3 2 1 1 1 1 1
0 3 3 3 3 3 3 3 3 2 2 1 1 1
0 3 3 3 3 3 3 3 3 2 1 1 1 1
0 3 3 3 3 3 3 3 3 2 2 2 2 1
0 3 3 3 3 3 3 3 3 2 2 1 1 0
0 3 3 3 3 3 3 3 2 1 1 1 1 1
0 3 3 3 3 3 3 3 2 1 1 1 1 1
0 3 3 3 3 3 3 3 3 3 2 1 1 1
0 3 3 3 3 3 3 3 2 2 2 2 1 1
0 3 3 3 3 3 3 3 2 2 2 1 1 1
0 3 3 3 3 3 3 3 3 1 1 1 1 1  
 
 Bromage scale  
The duration of motor block was prolonged in RF group as evidenced by 
more patients in bromage scale 3 even in 180 minutes. 
 
DURATION OF ANALGESIA 
 
 
 
                                There is a statistical significance in the difference between 
the two groups RF and BF.  p value < 0.001 .ie, The duration of analgesia is 
more in BF group . 
 
Duration of 
Analgesia 
(min) 
Group 
RF 
Group 
BF 
Mean 242.27 289.2 
SD 12.81 16.38 
 p value < 0.001 Significant 
SIDE EFFECTS 
 
PARAMETER Group   RF Group  BF 
Hypotension 3 8 
Bradycardia 1 1 
Nausea- vomiting 1 2 
Shivering 1 1 
Pruritus - - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 
Ropivacaine is a long acting, enantiomerically pure (S‑enantiomer) amide 
local anaesthetic, and with a low lipid solubility. The low lipid solubility of 
ropivacaine relates the lesser duration of analgesia comparing to Bupivacaine. 
Intrathecal ropivacaine, in animal studies has shown to produce effective sensory 
block, but the duration of motor block is shorter than intrathecal bupivacaine, 
with no signs of neurological side effects. 
 
The early motor recovery of ropivacaine is due to the  blockade of  nerve 
fibers involved  in transmission of pain (Aδ and C fibers) to a greater degree, 
comparing to  controlling of  motor functions (Aβ fibers).This feature favors its 
use where early ambulation is needed as in orthopaedic surgeries, for starting 
physiotherapy. This feature also allows for the detection of any neurological 
side-effects, if any, occurred.   
 
The present study has demonstrated that using either ropivacaine or 
bupivacaine intrathecally, with fentanyl as an adjuvant has provided satisfactory 
anesthetic conditions for lower limb ortho surgeries. Most of the sub‑arachnoid 
block characteristics were similar. There was a significant early motor recovery 
in RFgroup with haemodynamic stability, but BF provided a  prolonged duration 
of post‑operative analgesia. 
I proposed to study the efficacy of ropivacaine for major orthopaedic 
surgeries as an alternative to bupivacaine, using equimilligram dose (15 mg) as 
used by Luck et al. While maintaining the advantage of low dose local 
anaesthetic intrathecally, the use of analgesic adjuvants can improve the quality 
of intra ‑operative anaesthesia. Lipid soluble opioids such as sufentanil and 
fentanyl are the most commonly used adjuvants. Studies have shown that 
intrathecal opioids can enhance greatly the duration of analgesia of 
sub‑therapeutic doses of local anaesthetics. Fentanyl added to local anaesthetic 
agent intrathecally seems to be the most frequently used combination in spinal 
anesthesia, to enhance and increase the duration of sensory block, without 
intensifying the duration of motor blockade or prolonging the recovery from 
spinal anaesthesia. 
 
Both intrathecal RF and BF produced an initial moderate fall in blood 
pressure in keeping with the expected sympathetic blockade produced by the 
spinal anaesthesia. Although the Systolic BP stabilized after 30 min, there was a 
statistically significant difference among the two groups from 120 to 240 
minutes, where the systolic BP comes near the baseline values in RF group. This 
recovery profile of systolic blood pressure in the ropivacaine-fentanyl group 
more or less coincides with the recovery of motor block. 
 
My results are consistent with Lee et al. as I observed comparable levels 
of highest dermatome blocked, the time taken to reach the peak sensory and 
motor level and the two segment sensory regression time. The motor block was 
significantly shorter with Group RF, although it outlasted the duration of 
surgery. 
 
This feature is desirable as it encourages early ambulation, voiding and 
physiotherapy. Neurological side effects, if any, can also be detected early. The 
mean time duration of analgesia is significantly prolonged in Group BF when 
compared to Group RF. 
 
No patient in either group required intra-operative analgesia, since the 
duration of surgery is within the duration of sensory block in both groups.   
 
Intra operative hypotension requiring treatment with ephedrine occurred 
in 3 patients in Group RF as compared to 8 patients in Group BF. One patient in 
each group was also treated with 0.6 mg i.v atropine for bradycardia. The most 
common adverse effect noted was nausea and vomiting, experienced in both the 
groups. Shivering also occurred in both the groups. 
 
 
 
 
 
 
LIMITATIONS OF THE STUDY 
 
Though equimilligram doses of Ropivacaine and Bupivacaine were 
compared, the differences in baricity were not taken into consideration. Any 
impact of baricity on the spinal block characteristics was not measured, as only 
the dose was considered. 
 
Another limitation was the small sample size. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 
Intrathecal ropivacaine-fentanyl provides a satisfactory anesthesia and has 
a better hemodynamic stability for lower limb orthopaedic surgeries. 
 
The shorter duration of motor block compared to intrathecal Bupivacaine 
– Fentanyl is helpful in terms of early ambulation, voiding and for starting 
physiotherapy earlier. 
 
Although certain trends could be established in this study with 
encouraging results, further studies with larger sample sizes are needed to form a 
definitive opinion regarding the application of intrathecal Ropivacaine. 
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PROFORMA 
 
COMPARITIVE STUDY OF INTRATHECAL 
ROPIVACAINE –FENTANYL AND BUPIVACAINE- FENTANYL 
FOR LOWER LIMB ORTHOPAEDIC SURGERIES 
 
 
NAME   AGE    DIAGNOSIS 
SEX    HEIGHT   PROCEDURE 
AGE    WEIGHT   ANAESTHESIOLOGIST     
WARD       SURGEON  
ASA GRADE 
 
GROUP;   RF  
 
  BF    
 
PRE OPERATIVE CONDITION: 
 
PR                                                          CVS 
BP   RS 
Hb%                                                 ABDOMEN 
BT.CT                                                                    CNS 
Blood grouping/typing 
Blood Sugar                                                 Airway 
Urea  Mallampati score 
Creatinine                                                               Spine 
Serum Electrolytes   
Chest X-Ray 
ECG   
ECHO 
 ANAESTHETIC PLAN -   Subarachnoid block 
PRE LOADING: 
Drug: 
Dosage: 
Needle: 
Position: 
Level: 
No of Attempts: 
 
 
ASSESSMENT OF LEVEL OF BLOCK 
 
 
Peak sensory level; 
Time to reach peak sensory level (min); 
Time to reach peak motor blockade (min); 
Two segment sensory regression time (min); 
Time to motor regression to bromage grade 1(min); 
Duration of surgery (min); 
Duration of analgesia (min); 
Side effects; 
 
 
POST OPERATIVE 
 
 VAS  for   Analgesia Assessement 
 
 
MOTOR BLOCK GRADE  
Bromage grade in minutes after sub arachnoid block. 
0 5 10 30 60 90 120 150 180 210 240 270 300 360 
              
 
 
 
 
ASSESMENT OF HAEMODYNAMIC PARAMETERS 
 
PARAMETER 0 3 5 15 30 60 90 120 150 180 210 240 270 300 330 
Pulse rate                
Spo2                
Systolic BP                
Diastolic BP                
Mean Arterial 
Pressure  
               
 
 
 
 
 
 
 
 
ABBREVIATIONS  
 
RF        Ropivacaine-Fentanyl 
BF        Bupivacaine-Fentanyl 
ASA     American Society of Anaesthesiologists 
ECG     Electro Cardio Gram 
NIBP    Non-Invasive Blood Pressure 
SPO2    Pulse oximeter oxygen saturation 
BP         Blood Pressure 
MAP     Mean Arterial Pressure 
IV         IntraVenous 
VAS      Visual Analog Scale 
RL        Ringer Lactate 
 
1 Balamurugan 28 M 76 176 Calcaneum # ORIF 1 RF 4 6 8 68 252 158 262
2
Sethuramalinga
m
57 M 65 160
Compound 
#tibia
IL nail 2 RF 3 6 7 62 250 200 260
Hypotension
3 Isakki ammal 60 F 55 152 OA knee TKR 2 RF 3 7 8 71 238 210 256
4 Arumugam 58 M 62 163
#BB leg
ORIF –IL nail 2 RF 4 7 8 64 222 190 252
5 Muthukrishnan 29 M 76 174 SOF-IL nail Implat exit 1 RF 5 8 10 64 228 210 248
6 Alagukumar 34 M 84 181 #BB Leg CRIF 1 RF 6 8 9 72 228 180 238
7 Jebastin 54 M 74 164
Lateral tibial 
condyle #
ORIF -plating 2 RF 5 7 9 71 228 208 242
8 Annalakshmi 58 F 61 154
NOF# hemiarthropla
sty
2 RF 4 6 7 68 226 194 236
9 Annamalai 24 M 74 169 # Trochanter DHS 1 RF 5 7 9 65 234 198 242
10 Subbiah 58 M 68 168
#NOF hemiarthropla
sty
2 RF 4 6 9 64 236 208 258
11 Ramesh 50 M 66 165
Old bimalleolar 
#-implant in situ Implant exit 1 RF 5 5 7 62 208 210 222
12 kalyaniammal 58 F 57 157
# trochanter
DHS fixation 2 RF 3 5 9 64 213 210 228
Hypotension
13 Pitchaiyan 51 M 62 174
# tibial condyle ORIF with 
plate
2 RF 4 6 8 67 208 198 220
14 Murugan 54 M 68 178
Supracondylar # 
femur
ORIF with 
butress plate
2 RF 5 7 9 63 223 225 256
Shivering 
15 Ganesan 21 M 66 165
Patellar tendon 
injury with 
TBW
Implant exit 1 RF 4 5 9 67 218 168 230
16 Rosiah 27 M 68 169
Tibial plateau # ORIF with 
compression 
plate
1 RF 4 6 8 65 238 186 246
17 Soundarrajan 27 M 74 174
# SOF ORIF with K 
nail
1 RF 5 7 10 61 203 206 228
18 Thangaraj 45 M 68 172 # BB leg ORIF 2 RF 6 6 9 68 224 178 236
19 Ganesamurthy 22 M 83 186 #BB leg ORIF 1 RF 5 7 9 64 201 185 216
20 Chinnathai 57 F 64 158
OA knee
TKR 2 RF 4 5 8 69 215 188 234
Bradycardia
21 Paradesi 51 M 72 165 # tibia IL Nail 2 RF 4 5 7 66 248 186 262
22
Muthuramalinga
m
43 M 74 172
# trochanter
DHS 2 RF 5 7 9 63 223 200 242
23 Shanmugaiah 59 M 78 169 OA knee TKR 2 RF 4 6 8 67 238 178 254
24 Sheik mohamed 50 M 82 174
#NOF hemi 
arthroplasty
2 RF 5 5 9 68 226 168 258
25 Murugiah 38 M 68 168
Infected tibia 
nail
Implant exit 1 RF 4 7 10 61 214 138 232
26 Padma 56 F 63 157 #BB Leg ORIF 2 RF 3 5 8 68 220 176 244 Vomiting
27 Pandiyarajan 22 M 65 171
Posterior 
dislocation hip
ORIF 1 RF 4 6 9 62 218 188 244
28 Muthu 35 M 73 174
#SOF ORIF with 
IM nail
1 RF 6 5 7 65 228 198 242
29 Devendran 36 M 71 168
Closed SOF ORIF with K 
nail
1 RF 4 6 8 63 207 178 234
30 Rajesh 27 M 68 158
# talus ORIF wirh 
screw 
fixation
1 RF 4 6 9 61 213 146 246
Hypotension
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31 Kumar 30 M 68 176 # tibial condyle ORIF 1 BF 5 6 9 64 225 215 244
32 Amalraj 58 M 72 170
# trochanter DHS with 
PFN
2 BF 4 6 8 71 268 212 276
Nausea
33 Arulmurugan 44 M 76 168
# BB leg
ORIF 2 BF 4 7 9 67 275 185 288
Hypotension
34 Kumaraguru 37 M 68 169
Closed SOF ORIF with K 
nail
1 BF 5 7 10 72 256 196 273
35 Petchimuthu 55 M 68 171
# NOF hemi 
arthroplasty
2 BF 5 6 9 69 305 205 315
Shivering
36 Ramalakshmi 42 F 63 155
Non union 
malleolar # 
ankle
Ankle 
arthrodesis
1 BF 4 5 8 73 285 215 303
37 Angamuthu 54 M 64 165
Posterior 
dislocation hip
ORIF 1 BF 3 5 9 67 279 196 299
Hypotension
38 Prabhu 28 M 69 168 # tibia IL Nail 1 BF 4 6 10 75 256 165 276
39 Sivaraman 56 M 71 173
# talus ORIF wirh 
screw 
fixation
2 BF 4 6 9 68 260 152 300
40 Prakash 53 M 78 184
OA knee
TKR 2 BF 5 5 8 66 292 194 312
Hypotension
41 Arokiammal 35 F 65 155 # tibia ORIF 1 BF 4 5 9 72 275 208 295
42 Ganesh kumar 45 M 70 168
#SOF ORIF with 
IM nail
2 BF 6 7 10 65 255 214 285
43 Anjapuli 48 M 65 160 # tibia IL Nail 2 BF 5 6 9 69 276 196 285
44 Rajagopal 45 M 65 173
Calcaneum #
ORIF 2 BF 6 7 9 61 295 147 312
Hypotension
45 Aravind 22 M 73 169
Tibial plateau # ORIF with 
compression 
plate
1 BF 4 6 9 62 257 178 277
46 Thangapandi 38 M 68 173
Tibial plateau # ORIF with 
compression 
plate
1 BF 5 8 10 68 266 214 285
Vomiting
47 Muthu 43 M 70 164
Supracondylar # 
femur
ORIF with 
butress plate
1 BF 4 7 9 64 248 185 275
48 Arumugam 57 F 58 159
# trochanter
PFN 2 BF 4 6 8 64 292 218 305
Bradycardia
49 Chandran 53 M 65 163 # trochanter DHS 2 BF 5 6 9 65 255 225 269
50 Sivasankar 38 M 76 174 # tibia IL Nail 1 BF 6 7 9 66 264 185 282
51 Kumaresan 57 M 75 173
# NOF hemi 
arthroplasty
2 BF 5 6 9 68 306 215 315
Hypotension
52 Rajarathinam 57 M 75 162 # trochanter PFN 2 BF 4 7 10 62 295 185 312
53 Balasubramani 52 M 65 155
Tibial plateau # ORIF with 
compression 
plate
2 BF 4 6 9 67 285 178 298
Hypotension
54 Vasanthi 55 F 62 153 #BB leg ORIF 2 BF 4 7 9 63 275 196 285
55 Moorthi 28 M 64 171
Infected tibia 
nail
Implant exit 1 BF 5 5 8 61 260 142 276
56 Ravikumar 57 M 76 178
Old bimalleolar 
#-implant in situ Implant exit 2 BF 6 6 9 72 285 158 295
Hypotension
57 Thangaraju 43 M 65 163
Supracondylar # 
femur
ORIF with 
butress plate
2 BF 5 6 9 68 263 216 276
Hypotension
58 Veerapandi 24 M 69 168
Compound 
#tibia
IL Nail 1 BF 4 7 9 71 258 194 277
59 Petchiammal 45 F 65 153 OA Knee TKR 2 BF 4 5 8 66 275 186 297
60 Velmurugan 49 M 63 168
#BB leg
ORIF 2 BF 5 6 8 65 276 195 289
Hypotension
0 3 5 15 30 60 90 120 150 180 210 240 270 300 330 0 3 5 15 30 60 90 120 150 180 210 240 270 300 330
1 RF 126 125 123 119 110 111 108 113 114 119 118 116 116 117 119 84 80 84 80 84 81 81 81 85 86 87 76 84 79 80
2 RF 128 126 124 118 109 106 107 115 116 117 119 118 119 116 120 85 79 83 83 85 82 80 78 86 82 84 78 83 80 81
3 RF 130 128 126 120 112 112 114 120 122 122 124 126 124 124 120 86 80 84 84 86 82 84 82 86 86 88 86 84 80 84
4 RF 118 108 114 110 100 100 106 110 110 116 116 114 116 116 118 76 78 80 80 80 78 80 78 84 82 82 72 74 74 76
5 RF 119 115 116 114 111 110 107 111 112 117 117 115 117 118 119 119 79 81 81 81 79 82 79 85 83 83 73 75 76 77
6 RF 126 125 123 119 110 111 108 113 114 119 118 116 118 116 118 80 78 82 82 83 80 83 80 86 84 88 75 78 78 79
7 RF 128 126 124 118 109 106 107 115 116 117 119 118 116 117 119 84 80 84 80 84 81 81 81 85 86 87 76 84 79 80
8 RF 125 124 123 119 108 105 108 114 118 119 116 117 119 116 120 85 79 83 83 85 82 80 78 86 82 84 78 83 80 81
9 RF 129 126 125 118 109 103 111 113 116 120 117 116 118 119 119 86 80 80 84 86 78 82 82 84 84 86 82 80 74 83
10 RF 128 127 124 119 110 104 112 111 114 119 119 118 119 117 118 81 78 84 80 82 79 81 81 85 86 85 85 81 75 77
11 RF 129 125 123 117 109 109 113 116 113 117 118 117 116 119 120 76 79 83 83 81 80 80 78 84 85 84 74 75 76 76
12 RF 122 120 119 116 110 111 112 111 116 118 119 116 119 116 119 77 80 81 84 80 81 84 79 85 82 82 75 77 75 77
13 RF 124 126 125 118 111 109 110 116 115 120 118 117 116 118 118 78 78 80 80 83 82 80 82 84 84 86 73 78 78 79
14 RF 129 124 123 119 110 108 111 112 113 121 122 120 119 117 120 79 79 84 81 84 78 83 79 86 85 84 85 79 79 80
15 RF 126 122 120 116 109 107 106 111 112 117 120 122 122 122 119 80 80 83 84 85 79 84 78 85 83 82 84 84 80 76
16 RF 120 123 122 118 108 106 109 112 115 119 122 123 121 123 118 81 79 80 83 85 81 82 82 84 85 85 83 79 78 79
17 RF 124 126 125 112 110 109 110 115 114 118 120 124 122 124 120 84 80 81 80 80 82 83 79 86 84 88 80 78 79 82
18 RF 119 111 115 111 109 111 109 116 115 117 119 125 123 123 119 86 78 82 84 86 78 80 81 84 82 84 81 77 75 84
19 RF 129 126 122 119 110 106 107 114 112 119 118 119 118 119 118 78 79 83 80 84 79 84 80 85 83 85 82 75 79 83
20 RF 123 121 120 117 109 105 107 111 113 120 119 118 117 114 120 85 80 80 83 83 82 83 79 86 86 86 73 74 80 80
21 RF 119 126 124 115 108 104 100 112 111 121 120 119 118 116 119 84 79 84 84 85 78 80 78 84 84 82 79 75 74 76
22 RF 128 127 123 116 109 108 109 111 119 118 119 118 119 119 118 77 78 80 81 80 79 82 80 85 82 88 80 84 75 78
23 RF 127 125 122 118 110 107 108 114 113 119 118 116 117 116 120 85 79 83 80 84 80 81 81 86 86 84 81 80 79 79
24 RF 123 119 117 119 111 110 111 112 111 120 119 115 116 115 119 86 80 80 83 86 81 83 82 84 84 87 73 80 78 80
25 RF 120 118 115 116 109 111 112 113 115 117 118 119 118 117 120 78 78 81 84 80 82 83 79 85 85 86 75 84 77 75
26 RF 127 121 124 119 108 107 108 116 114 118 119 117 119 120 118 80 79 83 82 83 79 83 78 86 82 87 77 82 75 79
27 RF 122 120 118 117 110 109 107 111 113 120 122 125 122 121 119 82 80 80 83 84 78 80 80 84 86 84 78 83 80 80
28 RF 126 123 122 118 109 105 109 114 115 119 120 122 123 120 120 84 79 84 81 82 79 84 82 86 84 87 86 76 77 83
29 RF 119 117 115 114 110 109 107 111 112 118 119 120 122 122 118 86 78 83 82 83 80 81 81 85 83 88 85 74 74 84
30 RF 124 122 120 119 111 110 109 113 114 121 120 119 121 119 120 76 80 80 84 80 79 80 78 84 85 82 82 80 80 76
31 BF 126 122 120 118 114 112 110 110 112 114 114 116 122 122 120 86 80 84 82 84 82 84 82 86 86 88 86 84 80 84
32 BF 118 98 96 108 98 96 98 106 108 108 110 108 112 114 114 74 76 80 80 80 76 80 78 84 82 82 72 74 74 76
33 BF 119 118 119 117 113 111 109 107 109 110 111 110 114 115 115 75 77 83 81 81 77 81 81 85 86 83 73 75 75 77
34 BF 122 120 117 116 112 110 108 109 110 111 112 111 113 114 116 76 78 82 80 83 78 83 82 84 84 84 74 76 76 78
35 BF 120 119 118 117 113 111 109 106 111 112 113 112 114 116 117 78 79 81 82 82 79 82 80 86 82 88 78 77 80 79
36 BF 119 116 115 114 111 110 108 109 109 110 111 113 115 114 116 77 80 80 80 83 82 80 78 84 86 87 79 80 79 80
37 BF 123 122 119 116 113 111 107 106 111 111 110 111 116 115 118 76 79 83 82 80 81 82 79 85 84 86 81 84 78 81
38 BF 119 116 114 113 112 110 109 108 110 109 113 112 117 116 116 79 80 82 80 83 80 84 80 86 85 82 85 82 74 76
39 BF 119 118 117 116 113 100 108 107 109 110 112 111 113 114 114 80 76 80 81 82 81 83 81 84 86 84 84 83 75 80
40 BF 125 121 119 117 110 109 107 108 111 109 110 109 112 116 119 86 78 83 82 81 80 82 82 85 83 87 78 80 76 84
41 BF 122 119 116 115 112 111 109 107 109 110 111 110 113 117 114 82 77 84 80 80 80 81 78 86 84 88 76 77 77 76
42 BF 123 120 119 116 113 110 106 109 111 113 112 111 114 119 116 81 76 80 82 83 82 80 79 84 85 82 77 78 79 84
43 BF 121 118 116 115 112 109 107 107 109 110 113 115 116 118 117 86 80 82 81 82 80 84 82 85 82 83 73 79 80 80
44 BF 120 119 115 114 113 110 109 108 110 111 110 115 113 114 115 75 77 83 80 80 81 80 78 86 86 86 75 75 79 81
45 BF 124 122 119 116 112 111 108 107 109 110 112 114 112 115 116 76 78 80 82 84 82 84 79 84 84 84 75 80 74 84
46 BF 119 117 116 115 111 108 106 109 110 113 111 112 113 116 114 77 79 84 80 80 79 83 80 85 86 87 85 81 76 79
47 BF 122 120 119 114 113 109 107 108 109 111 113 111 112 116 119 78 80 83 81 83 82 82 81 86 82 88 86 82 75 76
48 BF 120 119 116 113 112 111 109 107 110 113 112 115 116 114 117 79 77 80 80 82 80 81 82 84 83 87 73 83 74 74
49 BF 125 121 119 117 113 110 108 109 111 112 110 111 113 117 116 80 79 83 81 84 82 80 78 85 84 85 74 84 80 82
50 BF 124 120 118 116 112 100 99 108 109 110 113 112 114 116 114 83 78 82 82 80 79 84 79 86 85 84 72 78 79 84
51 BF 119 116 115 115 111 109 100 107 110 111 112 112 116 115 117 84 80 80 80 83 82 83 82 84 84 82 78 79 74 83
52 BF 123 122 119 116 113 108 109 108 109 110 111 110 114 116 114 85 76 84 81 82 81 80 81 85 82 83 80 74 75 80
53 BF 119 115 114 113 112 100 101 107 110 111 113 112 113 117 116 86 80 80 82 84 79 81 78 86 86 88 82 75 76 78
54 BF 122 120 119 117 113 111 109 109 111 113 111 113 118 119 118 84 76 83 80 80 78 82 82 85 83 87 85 76 80 80
55 BF 125 122 118 116 112 109 108 107 109 112 113 112 116 118 114 77 79 84 81 83 77 83 81 84 82 88 86 78 78 84
56 BF 124 123 116 115 111 108 107 109 110 111 112 111 113 117 116 75 80 82 82 82 80 82 78 85 84 82 84 80 79 83
57 BF 119 114 113 114 113 111 109 108 111 110 111 115 114 116 115 74 77 81 80 83 81 80 79 86 82 84 83 83 74 81
58 BF 120 119 118 116 112 109 108 109 110 113 113 112 116 114 117 86 79 80 81 80 82 84 82 84 86 87 84 84 75 82
59 BF 125 122 119 117 113 110 107 108 109 110 112 111 112 116 116 84 79 83 82 84 79 83 81 85 84 86 72 80 79 74
60 BF 119 118 117 116 113 111 109 107 111 113 113 112 113 114 114 77 80 82 81 83 81 80 78 86 85 88 75 75 80 79
G
R
O
U
P
S
.N
O
SYSTOLIC BP (SBP) in minutes DIASTOLIC BP (DBP) in minutes
1 RF
2 RF
3 RF
4 RF
5 RF
6 RF
7 RF
8 RF
9 RF
10 RF
11 RF
12 RF
13 RF
14 RF
15 RF
16 RF
17 RF
18 RF
19 RF
20 RF
21 RF
22 RF
23 RF
24 RF
25 RF
26 RF
27 RF
28 RF
29 RF
30 RF
31 BF
32 BF
33 BF
34 BF
35 BF
36 BF
37 BF
38 BF
39 BF
40 BF
41 BF
42 BF
43 BF
44 BF
45 BF
46 BF
47 BF
48 BF
49 BF
50 BF
51 BF
52 BF
53 BF
54 BF
55 BF
56 BF
57 BF
58 BF
59 BF
60 BF
G
R
O
U
P
S
.N
O
0 3 5 15 30 60 90 120 150 180 210 240 270 300 330 0 3 5 15 30 60 90 120 150 180 210 240 270 300 330
98 95 97 93 93 91 90 92 95 97 97 89 95 92 93 78 65 62 64 62 64 62 69 75 83 67 65 68 69 63
99 95 97 95 93 90 89 90 96 94 96 91 95 92 94 65 83 96 94 93 95 93 71 85 81 69 69 75 68 73
101 96 98 96 95 92 94 95 98 98 100 99 97 95 96 62 64 62 64 62 64 62 63 61 62 65 62 63 62 61
90 88 91 90 87 85 89 89 93 93 93 86 88 88 90 94 88 96 94 93 95 93 96 93 92 94 93 95 92 92
119 91 93 92 91 89 90 90 94 94 94 87 89 90 91 63 65 63 65 65 65 63 65 62 63 94 63 65 64 62
95 94 96 94 92 90 91 91 95 96 98 89 91 91 92 68 87 64 67 69 74 64 67 65 73 65 64 67 65 92
99 95 97 93 92 89 90 92 95 96 98 90 95 92 93 70 88 77 69 72 73 65 69 75 83 67 65 68 69 63
98 94 96 95 93 90 89 90 97 94 95 91 95 92 94 74 64 78 72 92 65 69 71 85 81 69 69 75 68 73
100 95 95 95 94 86 92 92 95 96 96 93 93 89 95 78 67 88 92 72 85 68 73 92 71 72 68 85 70 83
97 94 97 93 91 87 91 91 95 97 96 96 94 89 91 80 65 90 93 65 65 70 75 90 63 92 70 80 90 81
94 94 96 94 90 90 91 91 94 96 95 88 89 90 91 86 83 96 94 77 69 90 77 62 83 93 90 81 92 71
92 93 94 95 90 91 93 90 95 94 94 89 91 89 91 94 82 79 92 78 79 92 78 65 90 94 92 63 71 63
93 94 95 93 92 91 90 93 94 96 97 88 91 91 92 63 79 95 79 92 89 71 79 69 70 92 71 95 79 83
96 94 97 94 93 88 92 90 95 97 97 97 92 92 93 62 78 94 70 65 90 79 85 88 75 79 79 92 75 90
95 94 95 95 93 88 91 89 94 94 95 97 97 94 90 77 75 90 67 69 92 75 88 89 85 70 75 76 85 70
94 94 94 95 93 89 91 92 94 96 97 96 93 93 92 79 69 91 69 70 72 85 90 75 88 67 85 86 76 75
97 95 96 91 90 91 92 91 95 95 99 95 93 94 95 88 76 74 84 80 65 76 92 61 91 69 76 77 73 85
97 89 93 93 94 89 90 93 94 94 96 96 92 91 96 90 88 76 94 90 70 73 93 65 62 84 73 74 81 88
95 95 96 93 93 88 92 91 94 95 96 94 89 92 95 92 64 89 64 89 83 81 65 93 92 94 81 82 80 91
98 94 93 94 92 90 91 90 95 97 97 88 88 91 93 94 70 85 69 82 84 80 75 80 75 90 80 83 84 62
96 95 97 94 93 87 87 89 93 96 95 92 89 88 90 74 65 77 89 69 94 84 85 92 77 65 84 82 85 92
94 94 94 93 90 89 91 90 96 94 98 93 96 90 91 75 86 96 84 68 95 85 95 70 74 67 85 88 86 75
99 94 96 93 93 89 90 92 95 97 95 93 92 91 93 76 77 62 82 66 64 86 96 82 82 69 86 90 88 77
98 93 92 95 94 91 92 92 93 96 98 87 92 90 93 89 67 65 62 75 77 88 76 72 72 68 88 89 90 74
92 91 92 95 90 92 93 90 95 96 97 90 95 90 90 90 69 88 72 88 87 90 86 62 69 72 90 92 92 82
96 93 97 94 91 88 91 91 95 94 98 90 94 90 92 94 77 77 91 92 92 92 66 92 90 75 92 95 72 72
95 93 93 94 93 88 89 90 94 97 97 94 96 94 93 93 78 94 65 72 90 93 67 85 89 70 93 92 75 69
98 94 97 93 91 88 92 93 96 96 98 98 92 91 95 90 79 92 66 62 88 65 87 85 85 78 65 66 65 90
97 91 94 93 92 90 90 91 94 95 98 97 90 90 95 64 83 80 69 93 79 77 70 75 81 80 77 78 69 89
92 94 93 96 90 89 90 90 94 97 95 94 94 93 91 63 85 77 83 80 78 78 75 76 82 85 78 79 70 85
99 94 96 94 94 92 93 91 95 95 97 96 97 94 96 61 63 64 65 63 67 63 64 67 63 63 64 65 64 62
89 83 85 89 86 83 86 87 92 91 91 84 87 87 89 84 87 88 95 84 86 84 82 88 92 89 85 87 90 91
90 91 95 93 92 88 90 90 93 94 92 85 88 88 90 62 64 65 75 82 68 83 65 68 64 63 64 68 65 64
91 92 94 92 93 89 91 91 93 93 93 86 88 89 91 64 66 66 85 81 75 67 75 69 67 84 82 69 66 85
92 92 93 94 92 90 91 89 94 92 96 89 89 92 92 83 64 68 93 64 76 80 81 70 68 82 65 70 88 64
91 92 92 91 92 91 89 88 92 94 95 90 92 91 92 80 86 69 67 74 70 65 61 71 75 81 75 71 87 82
92 93 95 93 91 91 90 88 94 93 94 91 95 90 93 75 85 70 93 75 81 63 71 85 76 64 81 85 75 65
92 92 93 91 93 90 92 89 94 93 92 94 94 88 89 70 84 74 78 82 83 80 75 82 70 74 61 82 76 75
93 90 92 93 92 87 91 90 92 94 93 93 93 88 91 74 82 78 72 80 86 83 78 80 81 75 71 80 68 81
99 92 95 94 91 90 90 91 94 92 95 88 91 89 96 70 80 70 79 70 67 65 79 70 83 82 75 70 69 61
95 91 95 92 91 90 90 88 94 93 96 87 89 90 89 76 81 75 89 79 69 82 69 69 86 80 78 69 75 71
95 91 93 93 93 91 89 89 93 94 92 88 90 92 95 80 65 74 91 69 70 72 70 79 67 70 79 79 85 75
98 93 93 92 92 90 92 90 93 91 93 87 91 93 92 79 66 88 89 80 75 75 80 85 69 79 69 85 80 78
90 91 94 91 91 91 90 88 94 94 94 88 88 91 92 83 69 80 70 82 70 79 66 80 70 69 70 80 81 79
92 93 93 93 93 92 92 88 92 93 93 88 91 88 95 82 67 77 76 75 79 78 70 81 75 80 80 81 85 69
91 92 95 92 90 89 91 90 93 95 95 94 92 89 91 80 65 85 69 78 80 83 80 85 70 82 66 85 86 70
93 93 95 92 93 91 90 90 94 92 96 94 92 89 90 61 66 84 67 79 85 65 70 72 79 75 70 72 89 80
93 91 92 91 92 90 90 90 93 93 95 87 94 87 88 69 86 69 90 65 79 70 75 73 80 78 80 73 90 66
95 93 95 93 94 91 89 88 94 93 93 86 94 92 93 68 65 75 80 80 86 79 75 79 85 79 70 79 64 70
97 92 94 93 91 86 89 89 94 93 94 85 90 91 94 70 85 77 70 82 77 80 79 85 79 65 75 85 67 80
96 92 92 92 92 91 89 90 93 93 92 89 91 88 94 74 87 88 66 83 80 72 78 83 86 80 75 83 75 70
98 91 96 93 92 90 90 90 93 91 92 90 87 89 91 78 69 64 77 75 84 69 66 82 77 82 79 82 76 75
97 92 91 92 93 86 88 88 94 94 96 92 88 90 91 79 75 70 87 77 69 70 69 69 65 83 78 69 71 75
97 91 95 92 91 89 91 91 94 93 95 94 90 93 93 84 79 77 94 65 70 75 81 70 90 75 66 70 70 79
93 93 95 93 93 88 91 90 92 92 96 95 91 91 94 80 75 79 65 69 72 78 82 75 91 77 69 75 89 78
91 94 93 93 92 89 90 88 93 93 92 93 91 92 94 63 76 86 95 80 75 82 75 84 77 65 81 84 85 66
89 89 92 91 93 91 90 89 94 91 93 94 93 88 92 78 74 85 69 82 79 79 64 69 78 69 82 69 84 69
97 92 93 93 91 91 92 91 93 95 96 93 95 88 94 79 85 68 70 64 81 80 73 70 79 80 75 70 80 81
98 93 95 94 94 89 91 90 93 93 95 85 91 91 88 63 79 62 80 65 86 82 82 75 65 82 64 75 65 82
91 93 94 93 93 91 90 88 94 94 96 87 88 91 91 82 86 61 90 69 85 65 80 87 75 64 73 87 70 75
MEAN ARTERIAL PRESSURE (MAP) in minutes PULSE RATE in minutes
1 RF
2 RF
3 RF
4 RF
5 RF
6 RF
7 RF
8 RF
9 RF
10 RF
11 RF
12 RF
13 RF
14 RF
15 RF
16 RF
17 RF
18 RF
19 RF
20 RF
21 RF
22 RF
23 RF
24 RF
25 RF
26 RF
27 RF
28 RF
29 RF
30 RF
31 BF
32 BF
33 BF
34 BF
35 BF
36 BF
37 BF
38 BF
39 BF
40 BF
41 BF
42 BF
43 BF
44 BF
45 BF
46 BF
47 BF
48 BF
49 BF
50 BF
51 BF
52 BF
53 BF
54 BF
55 BF
56 BF
57 BF
58 BF
59 BF
60 BF
G
R
O
U
P
S
.N
O
0 3 5 15 30 60 90 120 150 180 210 240 270 300 330 0 5 10 30 60 90 120 150 180 210 240 270 300 360
98 99 98 98 98 98 98 98 98 98 98 98 98 98 98 0 2 3 3 3 3 3 2 2 2 2 1 1 1
99 98 99 99 97 97 99 96 97 99 99 97 99 96 97 0 3 3 3 3 3 3 3 3 3 3 2 1 1
100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 0 3 3 3 3 3 3 3 2 2 2 2 1 1
97 98 97 97 97 97 97 96 97 96 97 97 97 96 97 0 3 3 3 3 3 3 2 2 2 2 2 1 0
98 99 98 98 98 98 98 98 98 98 98 98 98 98 98 0 3 3 3 3 3 3 3 3 3 1 0 0 0
99 98 99 99 97 97 99 96 97 99 99 97 99 96 97 0 3 3 3 3 3 3 3 3 3 3 2 1 0
100 100 100 97 99 99 97 97 99 100 97 99 97 97 99 0 2 3 3 3 3 3 3 2 2 2 2 1 1
97 98 99 99 100 100 98 98 97 96 98 100 98 98 100 0 3 3 3 3 3 3 1 1 1 1 0 0 0
98 99 97 97 98 98 99 99 98 97 100 98 99 99 98 0 3 3 3 3 3 3 3 2 2 1 1 1 0
99 98 98 98 97 97 98 96 100 98 99 97 100 96 97 0 3 3 3 3 3 3 3 2 2 2 1 1 0
97 99 97 99 100 99 97 98 99 99 98 98 97 97 98 0 3 3 3 3 3 3 2 2 1 1 0 1 0
98 100 99 100 98 98 99 97 98 96 99 99 98 100 99 0 2 3 3 3 3 3 3 2 2 2 1 1 0
99 98 100 98 99 97 100 99 100 97 97 100 99 98 100 0 3 3 3 3 3 3 3 2 2 1 1 0 0
98 99 99 97 97 99 98 100 97 98 100 98 97 99 98 0 3 3 3 3 3 3 3 3 3 3 2 1 1
99 100 97 99 100 98 97 98 99 99 97 97 99 96 97 0 3 3 3 3 3 3 2 2 2 1 1 0 0
97 98 98 97 99 97 99 97 98 100 98 99 98 97 99 0 3 3 3 3 3 3 3 2 1 1 0 0 0
100 99 99 98 98 99 100 99 100 96 99 100 97 96 100 0 2 3 3 3 3 3 3 3 2 1 1 0 0
97 100 100 97 97 97 98 96 98 97 97 98 99 97 98 0 3 3 3 3 3 3 3 3 3 1 1 1 1
98 99 97 99 100 98 97 97 99 96 100 99 100 99 99 0 3 3 3 3 3 3 2 2 1 1 0 0 0
99 98 98 100 99 97 99 99 97 98 99 97 99 98 97 0 3 3 3 3 3 3 3 3 2 1 1 1 0
97 99 97 99 97 99 100 98 98 100 98 100 97 100 100 0 3 3 3 3 3 3 3 3 2 1 1 1 0
98 98 99 98 98 98 98 99 97 96 97 98 98 98 98 0 2 3 3 3 3 3 3 3 3 1 1 0 0
99 99 97 97 99 97 97 100 99 98 98 99 99 99 99 0 3 3 3 3 3 3 2 2 1 1 0 0 0
97 100 98 100 97 98 99 97 100 97 99 97 98 97 97 0 3 3 3 3 3 3 3 3 1 1 1 1 1
98 99 100 99 98 97 100 98 98 99 97 99 97 96 99 0 3 3 3 3 3 3 3 3 1 1 1 1 0
100 98 99 97 97 99 97 99 97 96 99 98 99 97 98 0 3 3 3 3 3 3 3 3 1 1 1 0 0
98 99 97 98 100 97 98 97 100 100 98 99 98 96 99 0 3 3 3 3 3 3 3 2 1 1 1 1 1
97 100 98 99 99 100 99 99 98 98 97 97 97 98 97 0 2 3 3 3 3 3 3 3 1 1 1 0 0
98 98 99 97 98 98 97 100 99 97 100 100 100 96 100 0 3 3 3 3 3 3 3 3 1 1 1 0 0
99 99 97 98 97 97 100 98 97 96 99 99 98 97 99 0 3 3 3 3 3 3 3 3 1 1 1 1 1
100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 0 3 3 3 3 3 3 3 3 3 2 2 1 1
98 97 98 97 97 99 98 97 99 97 98 98 99 98 97 0 3 3 3 3 3 3 3 3 2 2 2 1 1
99 98 99 98 98 100 99 98 100 98 99 99 100 99 98 0 3 3 3 3 3 3 3 3 2 2 2 1 1
97 97 98 99 99 99 100 97 99 99 98 98 99 98 99 0 3 3 3 3 3 3 3 3 2 1 1 1 0
98 99 100 98 100 100 99 99 100 97 99 99 100 100 97 0 3 3 3 3 3 3 3 3 3 2 2 2 1
100 98 99 100 97 99 98 100 99 100 100 98 99 99 100 0 3 3 3 3 3 3 3 3 2 2 2 1 1
97 100 98 97 98 100 100 98 100 98 99 100 100 98 98 0 2 3 3 3 3 3 3 3 2 1 1 1 1
98 98 99 98 99 99 99 97 99 99 98 99 99 99 99 0 3 3 3 3 3 3 3 3 2 2 2 2 1
99 97 98 99 97 100 98 99 100 100 100 98 100 98 100 0 3 3 3 3 3 3 3 3 3 2 1 1 1
97 99 100 97 98 99 100 100 99 97 99 99 99 99 97 0 3 3 3 3 3 3 3 3 2 2 2 2 1
98 98 98 98 100 100 99 97 100 99 98 98 100 98 99 0 3 3 3 3 3 3 3 2 1 1 1 1 1
97 97 99 99 99 99 98 98 99 100 100 99 99 99 100 0 2 3 3 3 3 3 3 3 3 2 2 1 1
100 99 98 100 97 100 99 99 100 98 98 98 100 100 98 0 3 3 3 3 3 3 3 2 2 1 1 1 1
98 98 100 97 98 99 98 98 99 97 99 99 99 99 97 0 2 3 3 3 3 3 3 3 2 2 2 2 1
97 99 99 99 99 100 99 97 100 98 100 98 100 98 98 0 3 3 3 3 3 3 3 2 2 1 1 1 1
99 97 98 98 97 99 98 99 99 100 99 100 99 100 100 0 3 3 3 3 3 3 3 3 2 2 2 2 1
98 99 100 97 98 100 100 98 100 98 98 99 100 99 98 0 3 3 3 3 3 3 3 3 3 2 1 1 0
97 100 99 100 97 99 98 100 99 97 99 98 99 98 97 0 3 3 3 3 3 3 3 2 1 1 1 1 1
100 98 98 99 99 100 99 98 100 100 98 99 100 99 100 0 3 3 3 3 3 3 3 3 2 1 1 1 1
99 97 100 97 100 99 100 99 99 97 100 98 99 100 97 0 3 3 3 3 3 3 3 2 1 1 1 1 1
97 99 99 98 99 100 99 97 100 98 99 99 100 99 98 0 3 3 3 3 3 3 3 3 2 2 1 1 1
98 98 98 100 97 99 98 99 99 99 98 100 99 98 99 0 3 3 3 3 3 3 3 3 2 1 1 1 1
99 97 100 99 98 100 99 98 100 100 99 99 100 100 100 0 3 3 3 3 3 3 3 3 2 2 2 2 1
100 99 99 97 97 99 100 97 99 97 100 98 99 99 97 0 3 3 3 3 3 3 3 3 2 2 1 1 0
98 100 98 98 98 100 99 100 100 98 99 99 100 98 98 0 3 3 3 3 3 3 3 2 1 1 1 1 1
97 97 99 100 99 99 98 97 99 99 98 98 99 100 99 0 3 3 3 3 3 3 3 2 1 1 1 1 1
99 99 98 97 100 100 99 98 100 100 99 99 100 99 100 0 3 3 3 3 3 3 3 3 3 2 1 1 1
100 98 100 98 98 99 100 99 99 98 100 100 99 98 98 0 3 3 3 3 3 3 3 2 2 2 2 1 1
97 97 99 99 97 100 99 97 100 97 99 99 100 99 97 0 3 3 3 3 3 3 3 2 2 2 1 1 1
98 99 99 97 98 99 98 98 99 99 98 98 99 100 99 0 3 3 3 3 3 3 3 3 1 1 1 1 1
SPO2 in minutes MOTOR BLOCK GRADE in minutes

